Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


Articles published in J Infect

Retrieve available abstracts of 647 articles:
HTML format



Single Articles


    November 2022
  1. ZHOU J, Chen Y, Shao Z, Ding S, et al
    Continuing evolution and transmission of avian influenza A(H3N8) viruses is a potential threat to public health.
    J Infect. 2022 Nov 17:S0163-4453(22)00651-X. doi: 10.1016/j.jinf.2022.
    PubMed    


  2. CHEN Y, Fan L, Deng W, Lin Q, et al
    Highly Pathogenic Avian Influenza outbreaks amongst bird populations in Europe - a view from China.
    J Infect. 2022 Nov 3. pii: S0163-4453(22)00638.
    PubMed    


    October 2022
  3. HE WQ, Gianacas C, Muscatello DJ, Newall AT, et al
    Effectiveness of influenza vaccination in reducing influenza-like illness and related antibiotic prescriptions in adults from a primary care-based case-control study.
    J Infect. 2022 Oct 23. pii: S0163-4453(22)00626.
    PubMed     Abstract available


  4. TIAN J, Li M, Li Y, Bai X, et al
    H3N8 subtype avian influenza virus originated from wild birds exhibited dual receptor-binding profiles.
    J Infect. 2022 Oct 20. pii: S0163-4453(22)00622.
    PubMed     Abstract available


  5. NAZARETH J, Barr I, Sullivan SG, Goss C, et al
    Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients.
    J Infect. 2022 Oct 13. pii: S0163-4453(22)00604.
    PubMed    


  6. MEDINA MJ, Nazareth J, Dillon HM, Wighton CJ, et al
    Respiratory virus transmission using a novel viral challenge model: An observational cohort study.
    J Infect. 2022;85:405-411.
    PubMed     Abstract available


    September 2022
  7. LIU P, Xu J
    Resurgence of influenza virus activity during COVID-19 pandemic in Shanghai, China.
    J Infect. 2022 Sep 29. pii: S0163-4453(22)00555.
    PubMed    


  8. SUN H, Liu H, Liu Y, Pang Z, et al
    Genetic characterization of a novel quadruple reassortant influenza A (H1N2) virus from swine, China, 2021.
    J Infect. 2022 Sep 10. pii: S0163-4453(22)00538.
    PubMed    


  9. ATTI A, Insalata F, Carr EJ, Otter AD, et al
    Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: a nested case-control within the SIREN study.
    J Infect. 2022 Sep 8. pii: S0163-4453(22)00535.
    PubMed     Abstract available


  10. ZOU P, Li G, Ge X, Wang J, et al
    Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia.
    J Infect. 2022;85:334-363.
    PubMed    


  11. LI P, Niu M, Li Y, Xu M, et al
    Human infection with H3N8 avian influenza virus: A novel H9N2-original reassortment virus.
    J Infect. 2022 Sep 1. pii: S0163-4453(22)00519.
    PubMed    


  12. COOPER DJ, Lear S, Watson L, Shaw A, et al
    A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.
    J Infect. 2022 Sep 1. pii: S0163-4453(22)00514.
    PubMed     Abstract available


    August 2022
  13. LINA L, Zhendong G, Sevalie S, Fangfang Z, et al
    Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients.
    J Infect. 2022 Aug 28. pii: S0163-4453(22)00512.
    PubMed    


  14. KIM SH, Kyu Cho H, Jeon CH, Sung Ock H, et al
    Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia.
    J Infect. 2022 Aug 27. pii: S0163-4453(22)00477.
    PubMed    


  15. GIDARI A, Schiaroli E, Sabbatini S, Bastianelli S, et al
    Impact of SARS-CoV-2 Omicron Variants on Serum Neutralization in a Cohort of Healthcare Workers Vaccinated with BNT162b2.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00507.
    PubMed    


  16. MIZOUE T, Yamamoto S, Konishi M, Oshiro Y, et al
    Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00480.
    PubMed    


  17. WANG Y, Chen X, Xiao W, Zhao D, et al
    Rapid COVID-19 rebound in a severe COVID-9 patient during 20-day course of Paxlovid.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00478.
    PubMed    


  18. WAN EYF, Mok AHY, Yan VKC, Wang B, et al
    Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.
    J Infect. 2022 Aug 16. pii: S0163-4453(22)00472.
    PubMed    


  19. GOMEZ-CARBALLA A, Martinon-Torres F, Salas A
    Is SARS-CoV-2 an oncogenic virus?
    J Infect. 2022 Aug 9. pii: S0163-4453(22)00469.
    PubMed    


  20. CHANG YC, Hsiao CT, Chen WL, Su YD, et al
    BioFire FilmArray Respiratory Panel RP2.1 for SARS-CoV-2 detection: The pitfalls.
    J Infect. 2022 Aug 8. pii: S0163-4453(22)00468.
    PubMed    


  21. AIELLO TF, Puerta-Alcalde P, Chumbita M, Monzo P, et al
    Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19.
    J Infect. 2022 Aug 5. pii: S0163-4453(22)00461.
    PubMed    


  22. BASSETTI M, Zuccaro V, Asperges E, Scudeller L, et al
    Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, nonneutropenic, adult patients: an update including COVID-19 data.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00465.
    PubMed    


  23. AO Y, Li J, Wei Z, Wang Z, et al
    Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00462.
    PubMed    


    July 2022
  24. NOH JY, Cheong HJ, Kim WJ, Choi JY, et al
    Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination: Running title: Optimal vaccination interval and ceiling effect.
    J Infect. 2022 Jul 31. pii: S0163-4453(22)00456.
    PubMed    


  25. BOJKOVA D, Stack R, Rothenburger T, Kandler JD, et al
    Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.
    J Infect. 2022 Jul 30. pii: S0163-4453(22)00455.
    PubMed    


  26. DZINAMARIRA T, Moyo E, Moyo P, Pierre G, et al
    Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00445.
    PubMed    


  27. MURPHY SL, Halvorsen B, Barratt-Due A, Am DR, et al
    Remdesivir modifies interferon response in hospitalized COVID-19 patients.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00450.
    PubMed    


  28. LI M, Luo Q, Gong C, Li AH, et al
    Prospective Surveillance of Human Adenovirus in Acute Respiratory Infections Reveals Epidemiological Features and the Disappearance of Species B During the COVID-19 Pandemic in Beijing, China.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00423.
    PubMed    


  29. FU J, Luo Y, Fang X, Lu J, et al
    Genetic variation of Golgi membrane protein 1 is associated with COVID-19 disease.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00420.
    PubMed    


  30. VELLAS C, Kamar N, Izopet J
    Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00422.
    PubMed    


  31. HUANG L
    Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.
    J Infect. 2022 Jul 14. pii: S0163-4453(22)00418.
    PubMed    


  32. HAGIYA H, Hikita T, Habu T, Asada M, et al
    Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people.
    J Infect. 2022 Jul 11. pii: S0163-4453(22)00413.
    PubMed    


  33. KHANNA R, Htun HL, Lianjie AL, Kyaw WM, et al
    Staff and patient surveillance in hospitals: good sentinels for the emergence of new SARS-CoV-2 variants.
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00411.
    PubMed    


  34. VERA-LISE I, Dominik E, Elisabeth R, Kerstin H, et al
    "Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00412.
    PubMed    


  35. LI M, Yu T
    Statistical concern on evaluating the consistency between gargle samples and nasopharyngeal (NP) swabs in RT-qPCR-based mass screening approach for the diagnosis of COVID-19.
    J Infect. 2022 Jul 6. pii: S0163-4453(22)00408.
    PubMed    


  36. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00406.
    PubMed    


  37. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
    Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
    PubMed    


  38. GAO X, Zhang S, Gou J, Wen Y, et al
    Spike-mediated ACE2 down-regulation involved in the pathogenesis of SARS-CoV-2 infection.
    J Infect. 2022 Jul 3. pii: S0163-4453(22)00404.
    PubMed     Abstract available


  39. LUO Q, Li M, Li A, Gong C, et al
    Genetic diversity and epidemiological features of respiratory syncytial virus, Beijing, 2015-2019: A multicenter and all-age groups study.
    J Infect. 2022;85:75-85.
    PubMed     Abstract available


  40. YUAN W, Hou Y, Lin Q, Chen L, et al
    How China responds to Omicron.
    J Infect. 2022;85:90-122.
    PubMed    


  41. WEN F, Zhang X, Guo J, Liang Z, et al
    Emergence of H3N8 avian influenza viruses possessing tri-basic hemagglutinin cleavage sites in China.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00383.
    PubMed    


  42. YANG M, Li A, Wang Y, Tran C, et al
    Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: a meta-analysis.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00384.
    PubMed    


    June 2022
  43. CARBONELL R, Urgeles S, Salgado M, Rodriguez A, et al
    NEGATIVE PREDICTIVE VALUE OF PROCALCITONIN TO RULE OUT BACTERIAL RESPIRATORY CO-INFECTION IN CRITICAL COVID-19 PATIENTS.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00380.
    PubMed     Abstract available


  44. SACERDOTE C, Milani L, Castiglione A, Pagano E, et al
    Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: an Italian cohort study.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00379.
    PubMed    


  45. O'MORAIN N, Stack R, Doherty J, Tosetto M, et al
    Research Letter: Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00372.
    PubMed    


  46. REN Y, Liu Y, Zhang Z, Liu Y, et al
    SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00377.
    PubMed    


  47. FOURGEAUD J, Toubiana J, Chappuy H, Delacourt C, et al
    No durable impact of COVID-19 measures on the hospital burden of Respiratory Syncytial Virus (France, 2018-2022).
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00375.
    PubMed    


  48. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
    Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
    PubMed    


  49. YANG M, Li A, Jiang L, Wang Y, et al
    Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00369.
    PubMed    


  50. NIYOMNAITHAM S, Toh ZQ, Licciardi PV, Wongprompitak P, et al
    Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00370.
    PubMed    


  51. PENG H, Wu X, Xiong S, Li C, et al
    Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
    PubMed    


  52. HATCHER J, Gil E, Storey N, Brown JR, et al
    Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
    PubMed    


  53. COCHINO AV, Farkas OM, Ioan A
    Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
    PubMed    


  54. LAZARUS R, Taucher C, Brown C, Corbic I, et al
    Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
    PubMed     Abstract available


  55. COULSON JM, Adams A, Gray LA, Evans A, et al
    COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00363.
    PubMed    


  56. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
    Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
    PubMed    


  57. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
    PubMed    


  58. GABBI C, Renieri A, Strandvik B
    Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
    J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
    PubMed     Abstract available


  59. SANG L, Cheng B, Yu Y, Xi Y, et al
    The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
    PubMed    


  60. XU QY, Li QL, Jia ZJ, Wu MJ, et al
    Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
    PubMed    


  61. IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
    Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
    PubMed    


  62. LV P, Hu B, Hua R, Zhang J, et al
    A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
    PubMed    


  63. ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
    High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
    PubMed    


  64. MELLON G, Rouquette A, Fac C, Carton B, et al
    SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
    PubMed    


  65. ZHANG Y, Li J, Jiang L, Chen Q, et al
    Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
    PubMed    


  66. GUO Z, Zhao S, Ryu S, Mok CKP, et al
    Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
    PubMed    


  67. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
    PubMed    


  68. LI Y, Guo Y, Duan Y
    Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
    PubMed    


    May 2022
  69. WANG B, Fu J, Lu A, Yang J, et al
    Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
    J Infect. 2022 May 31. pii: S0163-4453(22)00337.
    PubMed    


  70. GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al
    SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
    J Infect. 2022 May 27. pii: S0163-4453(22)00315.
    PubMed    


  71. KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al
    A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.
    J Infect. 2022 May 23. pii: S0163-4453(22)00313.
    PubMed    


  72. SA R, Isidro J, Borges V, Duarte S, et al
    Unravelling the hurdles of a large COVID-19 epidemiological investigation by viral genomics.
    J Infect. 2022 May 21. pii: S0163-4453(22)00302.
    PubMed     Abstract available


  73. SOVIK S, Barrat-Due A, Kasine T, Olasveengen T, et al
    Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
    J Infect. 2022 May 20. pii: S0163-4453(22)00305.
    PubMed     Abstract available


  74. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.
    J Infect. 2022 May 20. pii: S0163-4453(22)00307.
    PubMed    


  75. CHENG D, Dong Y, Wen S, Shi C, et al
    A child with acute respiratory distress syndrome caused by avian influenza H3N8 virus.
    J Infect. 2022 May 13. pii: S0163-4453(22)00288.
    PubMed    


  76. LIU L, Fan X, Guan Q, Yu C, et al
    Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study.
    J Infect. 2022 May 13. pii: S0163-4453(22)00287.
    PubMed    


  77. WU X, Peng H, Xiong S, Li C, et al
    Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer: COVID-19 infection, severity and risk of endometrial cancer.
    J Infect. 2022 May 10. pii: S0163-4453(22)00261.
    PubMed    


  78. VAN GRONINGEN KM, Dao BL, Gounder P
    Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county.
    J Infect. 2022 May 9. pii: S0163-4453(22)00259.
    PubMed    


  79. ZHANG YM, Liu XZ, Lin MM, Zan JC, et al
    Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
    J Infect. 2022 May 9. pii: S0163-4453(22)00260.
    PubMed    


  80. LUCIJANIC M, Cikara T, Bistrovic P, Papic I, et al
    Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
    J Infect. 2022 May 2. pii: S0163-4453(22)00251.
    PubMed    


  81. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The LONG-COVID-EXP-CM multicenter study.
    J Infect. 2022;84:722-746.
    PubMed    


  82. MARIANI C, Borgonovo F, Capetti AF, Oreni L, et al
    Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
    J Infect. 2022;84:722-746.
    PubMed    


  83. WAN Z, Lu R, Zhao Y, Zhang C, et al
    Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy.
    J Infect. 2022 May 1. pii: S0163-4453(22)00250.
    PubMed    


    April 2022
  84. JIMENEZ D, Martinez-Sanz J, Sainz T, Calvo C, et al
    Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00248.
    PubMed     Abstract available


  85. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00247.
    PubMed    


  86. GIANNITRAPANI L, Augello G, Mirarchi L, Amodeo S, et al
    Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00245.
    PubMed    


  87. LI A, Zhang L
    Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00249.
    PubMed    


  88. RANA MS, Usman MM, Ikram A, Salman M, et al
    The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and Afghanistan. A dismal scenario.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00246.
    PubMed    


  89. YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
    Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00215.
    PubMed    


  90. NGUYEN NN, Houhamdi L, Hoang VT, Stoupan D, et al
    High rate of reinfection with the SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00216.
    PubMed    


  91. LI Y, Wei L, He L, Sun J, et al
    Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
    PubMed     Abstract available


  92. HE L, Zeng C, Xu W, Li Y, et al
    Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00214.
    PubMed    


  93. AO G, Li A, Wang Y, Tran C, et al
    Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00210.
    PubMed    


  94. CIUFFREDA L, Alcoba-Florez J, Lorenzo-Salazar JM, Gil-Campesino H, et al
    Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00212.
    PubMed    


  95. PANDIT P, Bhatt P, Sahay RR, Joshi Y, et al
    A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00205.
    PubMed    


  96. CAI J, Hu S, Lin Q, Ren T, et al
    China's 'dynamic zero COVID-19 strategy' will face greater challenges in the future.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00209.
    PubMed    


  97. DAVIES J, Gibani MM, Portone G, McGregor A, et al
    Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection.
    J Infect. 2022 Apr 12. pii: S0163-4453(22)00202.
    PubMed    


  98. REN Y, Lv L, Li P, Zhang L, et al
    Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction.
    J Infect. 2022 Apr 11. pii: S0163-4453(22)00201.
    PubMed    


  99. ZSIGMOND B, Breathnach AS, Mensah A, Ladhani SN, et al
    Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England".
    J Infect. 2022 Apr 10. pii: S0163-4453(22)00203.
    PubMed    


  100. WHITAKER H, Tsang RS, Button E, Andrews N, et al
    Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
    PubMed     Abstract available


  101. LIU X, Munro APS, Feng S, Janani L, et al
    Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
    PubMed     Abstract available


  102. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.
    PubMed    


  103. BADDAL B, Bostanci A
    The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.
    PubMed    


  104. CHENG CY, Hsiao SH, Fang TC, Lin YC, et al
    SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.
    PubMed    


  105. YADAV PD, Sahay RR, Agrawal S, Shete A, et al
    Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00193.
    PubMed    


  106. LIU Y, Li P, Yang L, Li P, et al
    High vaccination coverage slows down genetic diversity of SARS-CoV-2.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00191.
    PubMed    


  107. AKBAR S, Pan D, Ehdode A, Islam R, et al
    Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00195.
    PubMed    


  108. ONG JY, Wang CH, Ms YT, Chen FL, et al
    Nosocomial septicemia in COVID-19 Nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica Septicemia in a Patient of COVID-19.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00188.
    PubMed    


  109. SONG W, Yang Y, Huang Y, Chen L, et al
    Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00183.
    PubMed    


  110. GAGNAIRE J, Bonjean P, Verot E, Boulamail B, et al
    SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00184.
    PubMed    


  111. BAEK YJ, Lee YJ, Kim JI, Lee S, et al
    Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: a retrospective cohort study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00186.
    PubMed    


  112. DUVERGER C, Monteil C, Souyri V, Md SF, et al
    Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic.
    J Infect. 2022 Apr 1. pii: S0163-4453(22)00179.
    PubMed    


    March 2022
  113. YOON JG, Yoo JS, Lee J, Hyun HJ, et al
    Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
    J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.
    PubMed    


  114. MENG J, Ge Q, Li J, Lu X, et al
    Protective trend of anti-androgen therapy during the COVID-19 pandemic: a meta-analysis.
    J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.
    PubMed    


  115. SCHILDGEN V, Lusebrink J, Schildgen O
    Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnarable individuals.
    J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.
    PubMed    


  116. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
    J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.
    PubMed    


  117. YANG G, Ren Z, Zou Y, Xu Q, et al
    Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: lessons from the "dynamic zero-COVID policy" in mainland China.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00141.
    PubMed    


  118. MURGIA F, Fiamma M, Serra S, Olla S, et al
    The impact of secondary infections in COVID-19 critically ill patients.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.
    PubMed    


  119. DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al
    Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.
    J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.
    PubMed    


  120. RYAN P, Perez-Garcia F, Torres-Macho J, Bibiano C, et al
    Misdiagnosis rate of among negative COVID-19 patients in real-life with Panbio COVID-19 Antigen Rapid Test during 2021.
    J Infect. 2022 Mar 16. pii: S0163-4453(22)00139.
    PubMed    


  121. AO G, Wang Y, Li A, Tran C, et al
    The effect of canakinumab on clinical outcomes in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.
    PubMed    


  122. CHEN C, Tang J, Wang C, Wen W, et al
    Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients Discharged.
    J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.
    PubMed    


  123. XIANG B, Yang L, Ye Z, Ren T, et al
    Vaccination of Susceptible Animals Against SARS-CoV-2.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00131.
    PubMed    


  124. BONNET B, Chabrolles H, Archimbaud C, Brebion A, et al
    Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00132.
    PubMed    


  125. FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al
    Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.
    PubMed    


  126. FANTINI J, Devaux CA, Yahi N, Frutos R, et al
    The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.
    J Infect. 2022 Mar 6. pii: S0163-4453(22)00129.
    PubMed    


  127. SUN R, Jiang W, Liu S, Peng C, et al
    Emergence of Novel Reassortant H5N6 Influenza Viruses in Poultry and Humans in Sichuan Province, China, 2021.
    J Infect. 2022 Mar 5. pii: S0163-4453(22)00128.
    PubMed    


  128. AU WY, Ye C, Briner SL, Suarez GD, et al
    Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00123.
    PubMed    


  129. GIMENEZ E, Albert E, Burgos JS, Peiro S, et al
    SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
    PubMed     Abstract available


  130. BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al
    SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.
    PubMed    


  131. SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr
    Effectiveness of COVID-19 vaccines in Qatar.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.
    PubMed    


    February 2022
  132. HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al
    Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or ChAdOx1 and Heterologous Third Dose with BNT162b2.
    J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.
    PubMed    


  133. KONIG S, Hohenstein S, Leiner J, Hindricks G, et al
    National mortality data for Germany before and throughout the pandemic: there is an excess mortality exceeding COVID-19-attributed fatalities.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.
    PubMed    


  134. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.
    PubMed    


  135. PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
    The value of electrostatic potentials of the Spike Receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 Variants. of Concern.
    J Infect. 2022 Feb 23. pii: S0163-4453(22)00112.
    PubMed    


  136. DE MICHELENA P, Torres I, Ramos-Garcia A, Gozalbes V, et al
    Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.
    J Infect. 2022 Feb 22. pii: S0163-4453(22)00110.
    PubMed    


  137. SAHAY RR, Patil DY, Sapkal GN, Deshpande GR, et al
    SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00082.
    PubMed    


  138. TANG K, Wu X, Luo Y, Wei Z, et al
    Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00081.
    PubMed    


  139. LIPPI G, Nocini R, Henry BM
    Is SARS-CoV-2 Omicron (B.1.1.529) variant causing different symptoms?
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00077.
    PubMed    


  140. SAEED A, Ahmad B, Majaz S, Nouroz F, et al
    Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of Main Protease 3CL Mpro: Molecular Simulation Analysis.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.
    PubMed    


  141. ZHENG J, Wang Z, Li J, Zhang Y, et al
    High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.
    PubMed    


  142. KWOK KO, Wei WI, Ma BHM, Ip M, et al
    Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.
    PubMed    


  143. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected.
    J Infect. 2022 Feb 15. pii: S0163-4453(22)00073.
    PubMed    


  144. BLANCO I, Violan C, Suner C, Garcia-Prieto J, et al
    Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2022 Feb 13. pii: S0163-4453(22)00072.
    PubMed    


  145. YADAV PD, Sapkal GN, Sahay RR, Potdar VA, et al
    Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns.
    J Infect. 2022 Feb 11. pii: S0163-4453(22)00070.
    PubMed    


  146. RIGHI E, Mirandola M, Mazzaferri F, Dossi G, et al
    Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study.
    J Infect. 2022 Feb 9. pii: S0163-4453(22)00065.
    PubMed     Abstract available


  147. MIGUERES M, Dimeglio C, Tremeaux P, Abravanel F, et al
    Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant.
    J Infect. 2022 Feb 7. pii: S0163-4453(22)00054.
    PubMed    


  148. ZHOU W, Zhong L, Tang X, Huang T, et al
    The early warning and monitoring of COVID-19 by using Baidu Search Index in China.
    J Infect. 2022 Feb 6. pii: S0163-4453(22)00063.
    PubMed    


  149. LAZOR-BLANCHET C, Zygoura P, Dafni U, Lamoth F, et al
    Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
    J Infect. 2022 Feb 5. pii: S0163-4453(22)00062.
    PubMed    


  150. WESTROP SJ, Whitaker HJ, Powell AA, Power L, et al
    Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
    J Infect. 2022 Feb 4. pii: S0163-4453(22)00055.
    PubMed     Abstract available


  151. WU Z, Liu J, Zhang H, Chang YF, et al
    The emergence of the novel avian influenza virus (H10N3) in China, 2020-a cause for concern?
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00061.
    PubMed    


  152. CUI H, Liu J, Zhang L
    The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00057.
    PubMed    


  153. DIMEGLIO C, Migueres M, Mansuy JM, Saivin S, et al
    Antibody titers and breakthrough infections with Omicron SARS-CoV-2.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00060.
    PubMed    


  154. KIVIT C, Groen K, Jongbloed M, Linssen C, et al
    An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00058.
    PubMed    


  155. ESTOFOLETE CF, Fares GF, Banho CA, Sacchetto L, et al
    Predictors of death in COVID-19 vaccine breakthrough infections in Brazil.
    J Infect. 2022 Feb 2. pii: S0163-4453(22)00059.
    PubMed    


  156. HAVDAL LB, Boas H, Bekkevold T, Kran AB, et al
    The burden of respiratory syncytial virus in children under 5 years of age in Norway.
    J Infect. 2022;84:205-215.
    PubMed     Abstract available


  157. LI Z, Tao B, Hu Z, Yi Y, et al
    Effects of short-term ambient particulate matter exposure on the risk of severe COVID-19.
    J Infect. 2022 Feb 1. pii: S0163-4453(22)00052.
    PubMed     Abstract available


    January 2022
  158. LIVINGSTONE R, Lin H, Brendish NJ, Poole S, et al
    Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00049.
    PubMed     Abstract available


  159. XU W, Tang J, Chen C, Wang C, et al
    Safety and Efficacy of the Covid-19 Vaccine in children andor adolescents: A meta-analysis.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00050.
    PubMed    


  160. MATTIUZZI C, Lippi G
    COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00051.
    PubMed    


  161. JI G, Chen C, Zhou M, Wen W, et al
    Post-COVID-19 Fatigue among COVID-19 in patients discharged from hospital: A meta-analysis.
    J Infect. 2022 Jan 28. pii: S0163-4453(22)00031.
    PubMed    


  162. MENSAH AA, Lacy J, Stowe J, Seghezzo G, et al
    Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study.
    J Infect. 2022 Jan 24. pii: S0163-4453(22)00010.
    PubMed     Abstract available


  163. SCHEPERS M, Zanger P, Jahn K, Konig J, et al
    Multi-household social gatherings contribute to the second SARS-CoV-2 wave in Rhineland-Palatinate.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00028.
    PubMed     Abstract available


  164. RANA MS, Usman MM, Alam MM, Ikram A, et al
    Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00027.
    PubMed    


  165. GAO R, Xu Y, Zhu G, Zhou S, et al
    Genetic variation associated with COVID-19 is also associated with endometrial cancer.
    J Infect. 2022 Jan 22. pii: S0163-4453(22)00026.
    PubMed    


  166. DUCLOUX D, Bamoulid J, Chabannes M, Colladant M, et al
    Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00020.
    PubMed    


  167. MAO Q, Wang C, Zhou M, Wen W, et al
    A meta-analysis of the association between calprotectin and the severity of COVID-19.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00023.
    PubMed    


  168. FAVRESSE J, Bayart JL, David C, Dogne JM, et al
    Nucleocapsid Serum Antigen Determination in SARS-CoV-2 Infected Patients Using the Single Molecule Array Technology and Prediction of Disease Severity.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00022.
    PubMed    


  169. ELFIKY AA, Ibrahim IM
    Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view.
    J Infect. 2022 Jan 18. pii: S0163-4453(22)00015.
    PubMed    


  170. ZHANG Y, Jiang N, Qi W, Li T, et al
    Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations.
    J Infect. 2022 Jan 15. pii: S0163-4453(22)00017.
    PubMed    


  171. PILECKY M, Harm S, Bauer C, Zottl J, et al
    Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00011.
    PubMed    


  172. XU Y, Gao R, Zhu G, Zhou S, et al
    Genetic variation of allergic disease is associated with the susceptibility to COVID-19.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00016.
    PubMed    


  173. THANH TT, Nhan NTT, Anh NT, Chung LT, et al
    SARS-CoV-2 RNA loads in Vietnamese children.
    J Infect. 2022 Jan 13. pii: S0163-4453(22)00012.
    PubMed    


  174. LIN M, Chen H, Wang Y, Qiu S, et al
    A Model Study on Predicting New COVID-19 Cases in China Based on Social and News Media.
    J Infect. 2022 Jan 9. pii: S0163-4453(22)00009.
    PubMed    


  175. CHEN JM, Chen YQ, Sun YX
    Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00001.
    PubMed    


  176. HAN X, Xu P, Wang H, Mao J, et al
    Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00006.
    PubMed    


  177. FAUSTINI S, Shields A, Banham G, Wall N, et al
    Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00002.
    PubMed    


  178. DE MICHELENA P, Torres I, Albert E, Bracho A, et al
    Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00007.
    PubMed    


  179. BORMAN AM, Fountain H, Guy R, Casale E, et al
    Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00665.
    PubMed    


  180. WHITAKER HJ, Tsang RS, Byford R, Andrews NJ, et al
    Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups.
    J Infect. 2022 Jan 3. pii: S0163-4453(21)00664.
    PubMed     Abstract available


  181. MARRAMS ARM, Kobayashi T, Suzuki H, Alsuhaibani M, et al
    Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis.
    J Infect. 2022 Jan 1. pii: S0163-4453(21)00658.
    PubMed     Abstract available


    December 2021
  182. SIMIONATTO VZ, Evaristo M, Santos EV, Mello R, et al
    SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.
    J Infect. 2021 Dec 31. pii: S0163-4453(21)00660.
    PubMed    


  183. FINCH LS, Harris A, Lester C, Veal D, et al
    Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00657.
    PubMed     Abstract available


  184. KAWAHARA T, Ueki Y, Nawa N, Miyamae S, et al
    Who is a super-spreader? Determinants of people with higher PCR copy number of SARS-CoV-2 during Mar 2020 to June 2021 in Japan.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00656.
    PubMed    


  185. ARORA U, Priyadarshi M, Katiyar V, Soneja M, et al
    Novel risk factors for Coronavirus disease-associated mucormycosis(CAM): a case-control study during the outbreak in India.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00654.
    PubMed     Abstract available


  186. ZENG C, Ye Z, Fu L, Ye Y, et al
    Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00655.
    PubMed    


  187. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00642.
    PubMed    


  188. VENTERO MP, Moreno-Perez O, Molina-Pardines C, Paytuvi-Gallart A, et al
    Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00647.
    PubMed     Abstract available


  189. LAI X, Wang J, Duan J, Gong Y, et al
    Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia.
    J Infect. 2021 Dec 23. pii: S0163-4453(21)00640.
    PubMed    


  190. LI Y, Li P, Xi J, Yang J, et al
    Wild bird-origin H3N8 avian influenza virus exhibit well adaptation in mammalian host.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00637.
    PubMed    


  191. DAVIS W, Duque J, Huang QS, Olson N, et al
    Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012-2016.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00635.
    PubMed     Abstract available


  192. GENG Y, Zhang L
    The impact of non-pharmaceutical interventions during COVID-19 pandemic on three children infectious diseases in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00645.
    PubMed    


  193. MAANI AA, Wahaibi AA, Nazer W, Al-Zadjali N, et al
    The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00629.
    PubMed    


  194. QIN G, Yang J, Zhao C, Ren J, et al
    The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00634.
    PubMed    


  195. VINER R, Waddington C, Mytton O, Booy R, et al
    Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00633.
    PubMed     Abstract available


  196. SYED-ABDUL S, Babu AS, Bellamkonda RS, Itumalla R, et al
    Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from a public hospital in India.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00639.
    PubMed     Abstract available


  197. COLTELLA L, Ranno S, Piccioni L, Linardos G, et al
    Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00636.
    PubMed    


  198. ORENES-PINERO E, Navas-Carrillo D, Moreno-Docon A, Ortega-Garcia JA, et al
    Confirmation of SARS-CoV-2 airborne dissemination indoors using "COVID-19 traps".
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00630.
    PubMed     Abstract available


  199. KHURRAM M, Ali G, Awan UA, Afzal MS, et al
    COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus!
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00638.
    PubMed    


  200. GAO P, Zhang X, Zhang S, Yu Y, et al
    COVID-19 persists: Current risk of a recurrence of the epidemic in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00643.
    PubMed    


  201. COSTA R, Olea B, Bracho MA, Albert E, et al
    RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00641.
    PubMed    


  202. YAN F, Gao F
    Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00644.
    PubMed    


  203. RUBESHKUMAR P, John A, Narnaware M, M J, et al
    Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.
    PubMed    


  204. WANG R
    Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease.
    J Infect. 2021 Dec 21. pii: S0163-4453(21)00631.
    PubMed    


  205. MANOLACHE NG, Ursachi V, Scohy A, Desmet C, et al
    Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.
    J Infect. 2021 Dec 14. pii: S0163-4453(21)00597.
    PubMed    


  206. OWEN SI, Williams CT, Garrod G, Fraser AJ, et al
    Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.
    J Infect. 2021 Dec 11. pii: S0163-4453(21)00598.
    PubMed     Abstract available


  207. FANG X, Ming C, Cen Y, Lin H, et al
    Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study.
    J Infect. 2021 Dec 10. pii: S0163-4453(21)00596.
    PubMed     Abstract available


  208. MAK WA, Koeleman JGM, van der Vliet M, Keuren F, et al
    SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study.
    J Infect. 2021 Dec 9. pii: S0163-4453(21)00593.
    PubMed     Abstract available


  209. QUINTAO TSC, Slavov SN, de Oliveira PM, Bezerra RDS, et al
    Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection.
    J Infect. 2021 Dec 5. pii: S0163-4453(21)00585.
    PubMed    


  210. LUI G, Wong CK, Chan M, Chong KC, et al
    Host inflammatory response is the major marker of severe respiratory syncytial virus infection in older adults.
    J Infect. 2021;83:686-692.
    PubMed     Abstract available


    November 2021
  211. TANI N, Kawai N, Chong Y, Bando T, et al
    Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season.
    J Infect. 2021 Nov 30. pii: S0163-4453(21)00583.
    PubMed     Abstract available


  212. OESER C, Whitaker H, Linley E, Borrow R, et al
    Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.
    J Infect. 2021 Nov 30. pii: S0163-4453(21)00584.
    PubMed    


  213. HAN X, Xu J, Hou H, Yang H, et al
    Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis.
    J Infect. 2021 Nov 29. pii: S0163-4453(21)00582.
    PubMed    


  214. MENTZER DAJ, James T, Yongya M, Cox S, et al
    Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
    J Infect. 2021 Nov 26. pii: S0163-4453(21)00580.
    PubMed    


  215. ALDERSON MR, Arkwright PD, Bai X, Black S, et al
    Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
    J Infect. 2021 Nov 24. pii: S0163-4453(21)00578.
    PubMed     Abstract available


  216. BEHNOOD SA, Shafran R, Bennett SD, Zhang A, et al
    Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies.
    J Infect. 2021 Nov 20. pii: S0163-4453(21)00555.
    PubMed     Abstract available


  217. LEBOURGEOIS S, Menidjel R, Chenane HR, Ferre VM, et al
    Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00556.
    PubMed    


  218. LUO L, Luo T, Du M, Mei H, et al
    Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00557.
    PubMed    


  219. PAN D, Kim JW, Nazareth J, Assadi S, et al
    Quantification and prognostic significance of interferon-gamma secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19.
    J Infect. 2021 Nov 18. pii: S0163-4453(21)00554.
    PubMed    


  220. TSAI SC, Chang WW, Lee WS
    Analysis of an outbreak of COVID-19(alpha-variant) with rapid progression to mortality in Taipei, Taiwan.
    J Infect. 2021 Nov 17. pii: S0163-4453(21)00553.
    PubMed    


  221. TILLARD C, Chazard E, Faure K, Bartolo S, et al
    Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00549.
    PubMed     Abstract available


  222. CHAPPELL H, Patel R, Driessens C, Tarr AW, et al
    Immunocompromised children and young people are at no increased risk of severe COVID-19.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00548.
    PubMed     Abstract available


  223. YAN X, Zhu S, Jin Z, Chen G, et al
    Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00550.
    PubMed    


  224. BEN S, Xin J, Chen S, Jiang Y, et al
    Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks.
    J Infect. 2021 Nov 9. pii: S0163-4453(21)00546.
    PubMed     Abstract available


  225. MARTIN-VICENTE M, Berenguer J, Munoz-Gomez MJ, Diez C, et al
    Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19: Anti-SARS-CoV-2 S antibodies in PWH.
    J Infect. 2021 Nov 6. pii: S0163-4453(21)00545.
    PubMed    


  226. BURGI JJ, Rosslein M, Hornung H, Jentsch J, et al
    Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?: Indication of persistence of SARS-CoV-2?
    J Infect. 2021 Nov 5. pii: S0163-4453(21)00544.
    PubMed    


  227. GIMENEZ E, Alberola J, Torres I, Albert E, et al
    Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2021 Nov 2. pii: S0163-4453(21)00542.
    PubMed    


  228. HESKIN J, Pallett SJC, Mughal N, Jones R, et al
    Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: a qualitative analysis across two London hospitals.
    J Infect. 2021 Nov 1. pii: S0163-4453(21)00537.
    PubMed    


    October 2021
  229. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00538.
    PubMed    


  230. WANG J, Zou H, Corpe C
    An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00536.
    PubMed    


  231. YE Q, Liu H, Shang S
    Non-pharmaceutical interventions reduced the incidence and exacerbation of allergic diseases in children during the COVID-19 pandemic.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00541.
    PubMed    


  232. LUMLEY SF, Richens N, Lees E, Cregan J, et al
    Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic.
    J Infect. 2021 Oct 29. pii: S0163-4453(21)00540.
    PubMed     Abstract available


  233. LI X, Chen H, Lu L, Chen LL, et al
    High compliance to infection control measures prevented guest-to-staff transmission in COVID-19 quarantine hotels.
    J Infect. 2021 Oct 26. pii: S0163-4453(21)00533.
    PubMed    


  234. CHONG Y, Tani N, Goto T, Yonekawa A, et al
    Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00508.
    PubMed    


  235. EPAULARD O, Buisson M, Nemoz B, Marechal ML, et al
    Persistence at one year of neutralising antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00507.
    PubMed    


  236. GUPTA A, Bhoyar RC, Mirza S, Jolly B, et al
    SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.
    J Infect. 2021 Oct 19. pii: S0163-4453(21)00506.
    PubMed    


  237. GUO J, Yu H, Wang C, Yuan S, et al
    Re-emergence of Highly Pathogenic Avian Influenza A(H5N8) Virus In Domestic Goose, China.
    J Infect. 2021 Oct 17. pii: S0163-4453(21)00504.
    PubMed    


  238. WANG MH, Lou J, Cao L, Zhao S, et al
    Characterization of key amino acid substitutions and dynamics of the influenza virus H3N2 hemagglutinin.
    J Infect. 2021 Oct 7. pii: S0163-4453(21)00498.
    PubMed     Abstract available


  239. BOSHIER FAT, Venturini C, Stirrup O, Guerra-Assuncao JA, et al
    The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
    J Infect. 2021 Oct 2. pii: S0163-4453(21)00493.
    PubMed     Abstract available


  240. FERNANDEZ-DE-LAS-PENAS C, Gomez-Mayordomo V, de-la-Llave-Rincon AI, Palacios-Cena M, et al
    Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:496-522.
    PubMed    


  241. HUMBERT MV, Opurum PC, Brendish NJ, Poole S, et al
    A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
    J Infect. 2021 Oct 1. pii: S0163-4453(21)00492.
    PubMed     Abstract available


    September 2021
  242. A A, M F, J CO, Ejm M, et al
    Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.
    J Infect. 2021 Sep 30. pii: S0163-4453(21)00489.
    PubMed     Abstract available


  243. LEMENAND O, Coeffic T, Thibaut S, Colomb-Cotinat M, et al
    Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00486.
    PubMed     Abstract available


  244. FERRE VM, Lebourgeois S, Menidjel R, Collin G, et al
    Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00488.
    PubMed    


  245. LECOINTRE L, Venkatasamy A, Wehr M, Koch A, et al
    Multicentric evaluation of a 3D-printed simulator for COVID- 19 nasopharyngeal swab collection in testing centers.
    J Infect. 2021 Sep 24. pii: S0163-4453(21)00485.
    PubMed    


  246. DIMEGLIO C, Herin F, Martin-Blondel G, Miedouge M, et al
    Antibody titers and protection against a SARS-CoV-2 infection.
    J Infect. 2021 Sep 21. pii: S0163-4453(21)00483.
    PubMed    


  247. MCMILLAN T, Jones C, O'Connor CJ, Nolan D, et al
    Risk factors associated with bloodstream infections among critically ill patients with COVID-19.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00480.
    PubMed    


  248. ALEMANY A, Millat-Martinez P, Ouchi D, Corbacho-Monne M, et al
    Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00481.
    PubMed    


  249. LUNA-MUSCHI A, Borges IC, de Faria E, Barboza AS, et al
    Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00474.
    PubMed    


  250. FANG C, Zhou Z, Li J, Zhou M, et al
    Incident changes of rotavirus enteritis among children during the coronavirus disease-2019 pandemic in Hangzhou, China.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00478.
    PubMed    


  251. AWAN UA, Malik MW, Khan MI, Khattak AA, et al
    Predicting COVID-19 incidence in war-torn Afghanistan: A timely response is required!
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00473.
    PubMed    


  252. CHEN H, Zhao X, Li L, Yan S, et al
    Mental health and physical symptoms of people quarantined during the COVID-19 outbreak.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00479.
    PubMed    


  253. ZUO L, Ao G, Wang Y, Gao M, et al
    Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis.
    J Infect. 2021 Sep 14. pii: S0163-4453(21)00477.
    PubMed    


  254. QIU S, Wang D, Zhang Y, Hu Y, et al
    Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites.
    J Infect. 2021 Sep 13. pii: S0163-4453(21)00471.
    PubMed    


  255. OLEARO F, Norz D, Hoffman A, Grunwald M, et al
    Clinical performance and accuracy of a qPCR-based SARS-CoV-2 mass-screening workflow for healthcare-worker surveillance using pooled self-sampled gargling solutions: a cross-sectional study.
    J Infect. 2021 Sep 6. pii: S0163-4453(21)00451.
    PubMed     Abstract available


  256. QIU S, Zhang Y, Wang D, Hu Y, et al
    The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.
    J Infect. 2021 Sep 2. pii: S0163-4453(21)00449.
    PubMed    


  257. LIANG J, Wang Z, Liu Y, Zeng L, et al
    Epidemiology and co-infection patterns in patients with respiratory tract infections in southern China between 2018 and 2020.
    J Infect. 2021;83:e6-e8.
    PubMed    


  258. CHANDRA S, Rawal R
    The surge in Covid related mucormycosis.
    J Infect. 2021;83:381-412.
    PubMed    


  259. ALKALAMOUNI H, Hitti E, Zaraket H
    Adopting fresh air ventilation may reduce the risk of airborne transmission of SARS-CoV-2 in COVID-19 unit.
    J Infect. 2021 Sep 1. pii: S0163-4453(21)00450.
    PubMed    


    August 2021
  260. BHATTACHARYA A, Collin SM, Stimson J, Thelwall S, et al
    Healthcare-associated COVID-19 in England: a national data linkage study.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00443.
    PubMed     Abstract available


  261. STRALIN K, Bruce D, Wahlstrom E, Walther S, et al
    Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00448.
    PubMed    


  262. SNELL LB, Awan AR, Charalampous T, Alcolea-Medina A, et al
    SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00445.
    PubMed    


  263. QIU S, Hu Y, Cheng L
    A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.
    J Infect. 2021 Aug 26. pii: S0163-4453(21)00442.
    PubMed    


  264. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
    PubMed     Abstract available


  265. QIU S, Hu Y
    Are COVID-19 susceptibility genes related to lung cancer?
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00434.
    PubMed    


  266. MORALES-ORTEGA A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al
    Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00436.
    PubMed    


  267. GUIGON A, Faure E, Lemaire C, Chopin MC, et al
    Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00435.
    PubMed    


  268. KRAL S, Banfi C, Niedrist T, Sareban N, et al
    Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
    J Infect. 2021 Aug 22. pii: S0163-4453(21)00419.
    PubMed    


  269. WEISSMAN YL, Cooper L, Sternbach N, Ashkenazi-Hoffnung L, et al
    Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations -a systematic review and meta-analysis.
    J Infect. 2021 Aug 20. pii: S0163-4453(21)00417.
    PubMed     Abstract available


  270. TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
    The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
    PubMed    


  271. BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
    Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
    PubMed    


  272. WANG C, Kang K, Lan X, Fei D, et al
    Cytokinelevels in sputum, not serum, may be more helpful 1 for indicating the damage in the lung and the prognosis of severe COVID-19 - A Case Series.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00415.
    PubMed     Abstract available


  273. YOU YS, Kim JS
    Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
    J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
    PubMed     Abstract available


  274. GAO R, Zheng H, Liu K, Ji Z, et al
    Genesis, Evolution and Host Species Distribution of influenza A (H10N3) Virus in China.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00403.
    PubMed    


  275. KRETSCHMER A, Kossow A, Grune B, Schildgen O, et al
    False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00402.
    PubMed    


  276. DOUXFILS J, Gillot C, Mullier F, Favresse J, et al
    Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
    J Infect. 2021 Aug 15. pii: S0163-4453(21)00405.
    PubMed    


  277. ARANDA J, Oriol I, Martin M, Feria L, et al
    Long-term impact of COVID-19 associated acute respiratory distress syndrome.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00396.
    PubMed     Abstract available


  278. WEY EQ, Bristow C, Nandani A, O'Farrell B, et al
    Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00400.
    PubMed    


  279. LADHANI SN, Ireland G, Baawuah F, Beckmann J, et al
    Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00401.
    PubMed     Abstract available


  280. MOSELEY E, Williams P, Muir P, Marlow R, et al
    Influenza A/B and respiratory syncytial virus digital immunoassay evaluation in a paediatric emergency department.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00397.
    PubMed    


  281. COSTA R, Bueno F, Gimenez E, Bracho A, et al
    Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00398.
    PubMed    


  282. DONG M, Luo M, Li A, Xie H, et al
    Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00395.
    PubMed    


  283. FURUSE Y, Tsnchiya N, Miyahara R, Yasuda D, et al
    COVID-19 case-clusters and transmission chains in the communities in Japan.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00399.
    PubMed    


  284. ALLEN N, Brady M, Martin AIC, Domegan L, et al
    Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
    PubMed    


  285. YAHI N, Chahinian H, Fantini J
    Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00392.
    PubMed     Abstract available


  286. KHAN MI, Qureshi H, Khattak AA, Awan UA, et al
    Predicting COVID-19 incidence in Pakistan: It's time to act now!
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00393.
    PubMed    


  287. FERNANDEZ-DE-LAS-PENAS C
    Post-COVID Functional Limitations on Daily Living Activities are Associated with Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection and Internal Care Unit Admission: A Multicenter Study.
    J Infect. 2021 Aug 7. pii: S0163-4453(21)00391.
    PubMed    


  288. ZHANG J, Huang L, Chen Y, Wang X, et al
    Avian influenza H10 subtype viruses continuously pose threat to public health in China.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00386.
    PubMed    



  289. Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00388.
    PubMed    


  290. GOBBI F, Buonfrate D, Silva R, Martini D, et al
    Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00390.
    PubMed    


  291. LAMB G, Heskin J, Randell P, Mughal N, et al
    Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
    PubMed     Abstract available



  292. Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00387.
    PubMed    


  293. TANNER AR, Phan H, Brendish NJ, Borca F, et al
    SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
    J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
    PubMed     Abstract available


  294. CHEN J, Li X, Xu L, Xie S, et al
    Health threats from increased antigenicity changes in H5N6-dominant subtypes, 2020 China.
    J Infect. 2021;83:e9-e11.
    PubMed    


  295. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    PubMed    


  296. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    PubMed    


  297. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    PubMed     Abstract available


    July 2021
  298. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    PubMed     Abstract available


  299. BENE MC, Bittencourt MC, Chevallier P
    Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
    PubMed    


  300. LIM SY, Kim JY, Lee JA, Kwon JS, et al
    Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00375.
    PubMed    


  301. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    PubMed     Abstract available


  302. RANA MS, Usman M, Salman M, Alam MM, et al
    Potential impact of COVID-19 Pandemic on escalating antimicrobial resistance in Pakistan.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00368.
    PubMed    


  303. WHITTAKER R, Kristofferson AB, Seppala E, Salamanca BV, et al
    Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00366.
    PubMed    


  304. CIUFFREDA L, Salazar JML, Alcoba-Florez J, Rodriguez-Perez H, et al
    Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00373.
    PubMed    


  305. COSENTINO G, Bernard M, Ambroise J, Giannoli JM, et al
    SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00374.
    PubMed    


  306. EBANKS D, Faustini S, Shields A, Parry H, et al
    Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
    PubMed    


  307. ROBERT TANNER A
    Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00365.
    PubMed    


  308. GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
    Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
    PubMed     Abstract available


  309. LAI CK, Lui GC, Chen Z, Cheung YY, et al
    Comparison of Self-collected Mouth Gargle with Deep-throat Saliva Samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00354.
    PubMed    


  310. BOU-KARROUM L, Khabsa J, Jabbour M, Hilal N, et al
    Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review.
    J Infect. 2021 Jul 24. pii: S0163-4453(21)00360.
    PubMed     Abstract available


  311. LADHANI SN
    Crossing the Rubicon: a Fine Line between Waiting and Vaccinating Adolescents against COVID-19.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00357.
    PubMed     Abstract available


  312. GUDIOL C, Dura-Miralles X, Aguilar-Company J, Hernandez-Jimenez P, et al
    Co-infections and superinfections complicating COVID-19 in cancer patients: a multicenter, international study.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00356.
    PubMed     Abstract available


  313. MOMBELLI M, Hoschler K, Cavassini M, Pascual M, et al
    Seasonal Trivalent Inactivated Influenza Vaccine with Topical Imiquimod in Immunocompromised Patients: a Randomized Controlled Trial.
    J Infect. 2021 Jul 20. pii: S0163-4453(21)00353.
    PubMed     Abstract available


  314. GAO S, Lu Y, Luan J, Zhang L, et al
    Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00348.
    PubMed    


  315. MATTIUZZI C, Henry BM, Lippi G
    Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00347.
    PubMed    


  316. VANCHEESWARAN R, Willcox ML, Stuart B, Knight M, et al
    Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19.
    J Infect. 2021 Jul 14. pii: S0163-4453(21)00332.
    PubMed    


  317. AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG, et al
    N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.
    J Infect. 2021 Jul 10. pii: S0163-4453(21)00329.
    PubMed    


  318. NIITSU T, Shiroyama T, Hirata H, Noda Y, et al
    Cytomegalovirus infection in critically ill patients with COVID-19.
    J Infect. 2021 Jul 9. pii: S0163-4453(21)00330.
    PubMed    


  319. ANGELETTI S, Giovanetti M, Fogolari M, De Florio L, et al
    Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated Health Care worker in Italy.
    J Infect. 2021 Jul 5. pii: S0163-4453(21)00325.
    PubMed     Abstract available


  320. FAVRESSE J, Douxfils J
    Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination.
    J Infect. 2021 Jul 4. pii: S0163-4453(21)00327.
    PubMed    


  321. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    PubMed    


  322. ROCHA AS, Meireles M, Vilaca H, Guimaraes TC, et al
    Outcomes of Covid-19 Organizing Pneumonia in Critically Ill Patients: OUTCOMES OF COVID-19 ORGANIZING PNEUMONIA.
    J Infect. 2021 Jul 1. pii: S0163-4453(21)00322.
    PubMed    


    June 2021
  323. XIE D, Chu H, Yang D, Ding Q, et al
    A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.
    J Infect. 2021 Jun 30. pii: S0163-4453(21)00315.
    PubMed    


  324. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.
    PubMed    


  325. HSU L, Wisplinghoff H, Kossow A, Hurrass J, et al
    Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00320.
    PubMed    


  326. WANG Y, Niu S, Zhang B, Yang C, et al
    The whole genome analysis for the first human infection with H10N3 influenza virus in China.
    J Infect. 2021 Jun 27. pii: S0163-4453(21)00318.
    PubMed     Abstract available


  327. MENDEZ-BRITO A, Bcheraoui CE, Pozo-Martin F
    Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00316.
    PubMed     Abstract available


  328. TRE-HARDY M, Cupaiolo R, Wilmet A, Beukinga I, et al
    Waning antibodies in SARS-CoV-2 naive vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00314.
    PubMed    


  329. BUSKERMOLEN M, Te Paske K, van Beek J, Kortbeek T, et al
    Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: viral reactivation or inflammatory rebound?
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00310.
    PubMed    


  330. DIMEGLIO C, Herin F, Miedouge M, Da-Silva I, et al
    One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00312.
    PubMed    


  331. HOMMA Y, Katsuta T, Oka H, Inoue K, et al
    The incubation period of the SARS-CoV-2 B.1.1.7 variant is shorter than that of other strains.
    J Infect. 2021 Jun 16. pii: S0163-4453(21)00306.
    PubMed    


  332. ANDERSEN MP, Ostergaard L, Phelps M, Butt JH, et al
    Risk of Coronavirus Disease 2019 (Covid-19) Contraction and Severe Infection in Home- or Healthcare Professionals.
    J Infect. 2021 Jun 15. pii: S0163-4453(21)00305.
    PubMed    


  333. CENDEJAS-BUENO E, Romero-Gomez MP, Escosa L, Jimenez-Rodriguez S, et al
    Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
    J Infect. 2021 Jun 13. pii: S0163-4453(21)00289.
    PubMed     Abstract available


  334. LOFFREDO L, Oliva A, Paraninfi A, Ceccarelli G, et al
    An observed association between conjunctivitis and severity of COVID-19.
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00286.
    PubMed    


  335. KWOK KO, McNeil EB, Tsoi MTF, Wei VWI, et al
    Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00287.
    PubMed     Abstract available


  336. NOH JY, Song JY, Hyun HJ, Yoon JG, et al
    Risk factors for SARS-CoV-2 transmission in non-household clusters.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00284.
    PubMed    


  337. RISTIC S, Pavlic SD, Nadalin S, Cizmarevic NS, et al
    ACE I/D polymorphism and epidemiological findings for COVID-19: one year after the pandemic outbreak in Europe.
    J Infect. 2021 Jun 4. pii: S0163-4453(21)00282.
    PubMed    


  338. LORENZO VB, Nascimento-Carvalho C
    Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.
    J Infect. 2021 Jun 3. pii: S0163-4453(21)00280.
    PubMed     Abstract available


  339. FANTINI J, Yahi N, Azzaz F, Chahinian H, et al
    Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks.
    J Infect. 2021 Jun 2. pii: S0163-4453(21)00281.
    PubMed     Abstract available


  340. STANG A, Robers J, Schonert B, Jockel KH, et al
    The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00265.
    PubMed    


  341. OLEA B, Albert E, Torres I, Gozalvo-Rovira R, et al
    Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00279.
    PubMed    


    May 2021
  342. KONTOGIANNI K, Cubas-Atienzar AI, Wooding D, Buist K, et al
    Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B.1.1.7 lineage.
    J Infect. 2021 May 29. pii: S0163-4453(21)00272.
    PubMed    


  343. TANG JW, Bird PW, Holmes CW, Nicoara DC, et al
    The UK Leicester COVID-19 'exceedance' May-July 2020: An analysis of hospitalised cases.
    J Infect. 2021 May 29. pii: S0163-4453(21)00270.
    PubMed    


  344. ZHANG N, Chen X, Jia W, Jin T, et al
    Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19.
    J Infect. 2021 May 29. pii: S0163-4453(21)00273.
    PubMed     Abstract available


  345. YAN X, Huang H, Wang C, Jin Z, et al
    Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery.
    J Infect. 2021 May 29. pii: S0163-4453(21)00276.
    PubMed    


  346. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    PubMed    


  347. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    PubMed    


  348. PALLOTTO C, Blanc P, Esperti S, Suardi LR, et al
    Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    J Infect. 2021 May 28. pii: S0163-4453(21)00267.
    PubMed    


  349. THANGARAJ JWV, Kumar MS, Kumar CG, Kumar VS, et al
    Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.
    J Infect. 2021 May 28. pii: S0163-4453(21)00268.
    PubMed    


  350. BREATHNACH AS, Duncan CJA, Bouzidi KE, Hanrath AT, et al
    Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.
    J Infect. 2021 May 27. pii: S0163-4453(21)00266.
    PubMed    


  351. CAPETTI AF, Borgonovo F, Mileto D, Gagliardi G, et al
    One-year durability of anti-spike IgG to SARS-CoV-2: preliminary data from the AntiCROWN prospective observational study One year durability of COVID-19 anti-spike IgG.
    J Infect. 2021 May 27. pii: S0163-4453(21)00264.
    PubMed     Abstract available


  352. VENTURAS J, Zamparini J, Shaddock E, Stacey S, et al
    Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
    J Infect. 2021 May 26. pii: S0163-4453(21)00262.
    PubMed     Abstract available


  353. J BP, Jolly B, John N, Bhoyar RC, et al
    Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
    J Infect. 2021 May 24. pii: S0163-4453(21)00260.
    PubMed    


  354. YAMAMOTO S, Tanaka A, Oshiro Y, Ishii M, et al
    Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    J Infect. 2021 May 24. pii: S0163-4453(21)00259.
    PubMed    


  355. HASAN MJ, Rabbani R, Anam AM, Huq SMR, et al
    Secukinumab in severe COVID-19 pneumonia: does it have a clinical impact?: Secukinumab in severe COVID-19.
    J Infect. 2021 May 21. pii: S0163-4453(21)00253.
    PubMed    


  356. SZARPAK L
    Mucormycosis - a serious threat in the COVID-19 pandemic?
    J Infect. 2021 May 21. pii: S0163-4453(21)00257.
    PubMed    


  357. FONSECA V, de Jesus R, Adelino T, Reis AB, et al
    Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.
    J Infect. 2021 May 21. pii: S0163-4453(21)00256.
    PubMed    


  358. BORDI L, Parisi G, Sberna G, Amendola A, et al
    Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: a pilot project.
    J Infect. 2021 May 20. pii: S0163-4453(21)00254.
    PubMed    


  359. CARAMELLO V, Boccuzzi A, Basile V, Ferraro A, et al
    Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital.
    J Infect. 2021 May 20. pii: S0163-4453(21)00255.
    PubMed    


  360. ZARIF A, Joy M, Sherlock J, Sheppard JP, et al
    The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    J Infect. 2021 May 15. pii: S0163-4453(21)00220.
    PubMed     Abstract available


  361. CHIRICO F, Nucera G, Szarpak L
    COVID-19 mortality in Italy: The first wave was more severe and deadly, but only in Lombardy region.
    J Infect. 2021 May 13. pii: S0163-4453(21)00248.
    PubMed    


  362. KOROMPOKI E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al
    Epidemiology and organ specific sequelae of post-acute COVID19: A Narrative Review.
    J Infect. 2021 May 13. pii: S0163-4453(21)00247.
    PubMed     Abstract available


  363. KOW CS, Merchant HA, Hasan SS
    Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.
    J Infect. 2021 May 13. pii: S0163-4453(21)00250.
    PubMed    


  364. HOTHAM M
    Potential future implications of the COVID-19 pandemic on Norovirus infections in England.
    J Infect. 2021 May 13. pii: S0163-4453(21)00241.
    PubMed    


  365. MANN JA, Bird PW, Bandi S, Tang JW, et al
    Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021.
    J Infect. 2021 May 13. pii: S0163-4453(21)00240.
    PubMed    


  366. WINCHESTER S, John S, Jabbar K, John I, et al
    Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection.
    J Infect. 2021 May 13. pii: S0163-4453(21)00251.
    PubMed     Abstract available


  367. WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
    Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
    J Infect. 2021 May 11. pii: S0163-4453(21)00224.
    PubMed     Abstract available


  368. FERNANDEZ-VILLA T, Vazquez-Casares A, Rivero-Rodriguez A, Carvajal-Urena A, et al
    Rapid antigen test for SARS-CoV-2 and primary health care.
    J Infect. 2021 May 7. pii: S0163-4453(21)00226.
    PubMed    


  369. SANSONE E, Tiraboschi M, Sala E, Albini E, et al
    Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
    J Infect. 2021 May 6. pii: S0163-4453(21)00225.
    PubMed     Abstract available


  370. MACLOT F, Bontems S, Meex C, Artesi M, et al
    Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.
    J Infect. 2021 May 3. pii: S0163-4453(21)00221.
    PubMed    


  371. MATAKI N, Ohmura H, Kodama T, Nakamura S, et al
    Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19.
    J Infect. 2021;82:186-230.
    PubMed    


  372. RICCO M, Ranzieri S, Marchesi F
    Rapid antigen tests for large-scale diagnostic campaigns: A case study from North-Eastern Italy.
    J Infect. 2021;82:e39-e40.
    PubMed    


    April 2021
  373. DE PAULA CSY, Palandri GG, Fonseca TS, Vendramini TCA, et al
    Gastrointestinal manifestations are associated with severe pediatric COVID-19: a study in tertiary hospital.
    J Infect. 2021 Apr 30. pii: S0163-4453(21)00217.
    PubMed    


  374. GARVEY MI, Wilkinson MAC, Holden E, Shields A, et al
    Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00214.
    PubMed    


  375. CHUDASAMA DY, Flannagan J, Collin SM, Charlett A, et al
    Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012-01) in England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00216.
    PubMed    


  376. VUSIRIKALA A, Whitaker H, Jones S, Tessier E, et al
    Seroprevalence of SARS-CoV-2 Antibodies in University Students: cross-sectional study, December 2020, England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00215.
    PubMed     Abstract available


  377. TEYSSOU E, Soulie C, Visseaux B, Lambert-Niclot S, et al
    The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00211.
    PubMed    


  378. BAEK YJ, Lee YJ, Yoon JS, Sohn Y, et al
    Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: a longitudinal study.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00212.
    PubMed    


  379. BONGIOVANNI M, Arienti R, Bini F, Bodini BD, et al
    Differences between the waves in Northern Italy: how the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00210.
    PubMed    


  380. GARVEY MI, McMurray C, Casey AL, Ratcliffe L, et al
    Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00213.
    PubMed    


  381. GALOW L, Haag L, Kahre E, Blankenburg J, et al
    Lower household transmission rates of SARS-CoV-2 from children compared to adults.
    J Infect. 2021 Apr 27. pii: S0163-4453(21)00209.
    PubMed    


  382. MARTIN-SANCHEZ M, Lim WW, Yeung A, Adam DC, et al
    COVID-19 transmission in Hong Kong despite universal masking.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00205.
    PubMed     Abstract available


  383. LI KK, Woo YM, Stirrup O, Hughes J, et al
    Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00206.
    PubMed     Abstract available


  384. CHEN S, Zhang X, Zhou Y, Yang K, et al
    COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00204.
    PubMed    


  385. STOCKDALE AJ, Fyles F, Farrell C, Lewis J, et al
    Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00198.
    PubMed     Abstract available


  386. FAROOQ HZ, Davies E, Brown B, Whitfield T, et al
    Real-world SARS CoV-2 Testing in Northern England during the first wave of the COVID-19 Pandemic.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00199.
    PubMed     Abstract available


  387. FU H, Zhang N, Zheng Y, Jiang N, et al
    Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients.
    J Infect. 2021 Apr 19. pii: S0163-4453(21)00202.
    PubMed    


  388. BARO B, Rodo P, Ouchi D, Bordoy AE, et al
    Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison.
    J Infect. 2021 Apr 18. pii: S0163-4453(21)00191.
    PubMed     Abstract available


  389. KODANA M, Kitagawa Y, Takahashi R, Matsuoka M, et al
    Concerns about the clinical usefulness of saliva specimens 1 for the diagnosis of COVID-19.
    J Infect. 2021 Apr 16. pii: S0163-4453(21)00194.
    PubMed    


  390. ALCOBA-FLOREZ J, Lorenzo-Salazar JM, Gil-Campesino H, Inigo-Campos A, et al
    Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020.
    J Infect. 2021 Apr 12. pii: S0163-4453(21)00168.
    PubMed    


  391. DONADIO C, Rainone A, Gouronnec A, Belmin J, et al
    Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: a case series in a geriatric rehabilitation ward during an outbreak.
    J Infect. 2021 Apr 11. pii: S0163-4453(21)00167.
    PubMed    


  392. BONGIOVANNI M, Marra AM, Bini F, Bodini BD, et al
    COVID-19 reinfection in healthcare workers: a case series.
    J Infect. 2021 Apr 8. pii: S0163-4453(21)00165.
    PubMed    


  393. LIU Y, Chen H, Tan W, Kuang Y, et al
    Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy.
    J Infect. 2021 Apr 5. pii: S0163-4453(21)00163.
    PubMed    


  394. TABOADA M, Gonzalez M, Alvarez A, Eiras M, et al
    First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00160.
    PubMed    


  395. NAYAGAM JS, Jeyaraj R, Mitchell T, Walder DP, et al
    Persistent cholestasis in survivors of SARS-CoV-2.
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00162.
    PubMed    


  396. OGURI S, Fujisawa S, Kamada K, Nakakubo S, et al
    Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2.
    J Infect. 2021 Apr 3. pii: S0163-4453(21)00159.
    PubMed    


  397. GARCIA-PACHON E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, et al
    Low prevalence of post-COVID-19 syndrome in patients with asthma.
    J Infect. 2021 Apr 2. pii: S0163-4453(21)00156.
    PubMed    


    March 2021
  398. MASIA M, Padilla S, Galiana A, Fernandez-Gonzalez M, et al
    Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.
    J Infect. 2021 Mar 29. pii: S0163-4453(21)00152.
    PubMed    


  399. PILLAI A, Koduri K, Gokhale Y, Venkatesh M, et al
    Covid-19 Letter to the Editor.
    J Infect. 2021 Mar 28. pii: S0163-4453(21)00154.
    PubMed    


  400. MULCHANDANI R, Taylor-Philips S, Jones HE, Ades AE, et al
    Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers.
    J Infect. 2021 Mar 25. pii: S0163-4453(21)00151.
    PubMed     Abstract available


  401. WILLIAMS CM, Pan D, Decker J, Wisniewska A, et al
    Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with covid-19.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00135.
    PubMed     Abstract available


  402. CHAU DNVV
    Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00133.
    PubMed    


  403. HARRIS RJ, Whitaker HJ, Andrews NJ, Aiano F, et al
    Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00132.
    PubMed     Abstract available


  404. HIROTSU Y, Omata M
    Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00130.
    PubMed    


  405. MURRAY MJ, McIntosh M, Atkinson C, Mahungu T, et al
    Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
    J Infect. 2021 Mar 19. pii: S0163-4453(21)00127.
    PubMed     Abstract available


  406. THARMARAJAH E, Buazon A, Patel V, Hannah JR, et al
    IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00125.
    PubMed     Abstract available


  407. WILLIAMS P, McWilliams C, Soomro K, Harding I, et al
    The dynamics of procalcitonin in COVID-19 patients admitted to Intensive Care Unit - A multi-centre cohort study in the South West of England, UK.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00128.
    PubMed    


  408. GARVEY MI, Casey AL, Wilkinson MAC, Ratcliffe L, et al
    Details of SARS-CoV-2 reinfections at a major UK tertiary centre.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00122.
    PubMed    


  409. BIRD PW, Holmes C, Fletcher O, Badhwar V, et al
    Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00124.
    PubMed     Abstract available


  410. SHAN FZ, Zhu LL, Zhang Y, Tang YH, et al
    Comparison of the role of neutrophil extracellular traps between patients admitted to the intensive care unit with influenza A and B virus infection.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00121.
    PubMed    


  411. REBOIRO MLL, Fuentetaja RS, Lopez RG, Castro-Conde BA, et al
    Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00123.
    PubMed    


  412. CHAUDHRY Z, Shawe-Taylor M, Rampling T, Cutfield T, et al
    Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.
    J Infect. 2021 Mar 11. pii: S0163-4453(21)00115.
    PubMed     Abstract available


  413. YANG H, Hou H, Liang X, Xu J, et al
    Lack of significant association between dyslipidemia and COVID-19 mortality.
    J Infect. 2021 Mar 5. pii: S0163-4453(21)00114.
    PubMed    


  414. MARTYN EM, Whitaker H, Gil E, Ighomereho P, et al
    Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
    J Infect. 2021 Mar 4. pii: S0163-4453(21)00098.
    PubMed    


  415. YOUNG BC, Eyre DW, Jeffery K
    Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00096.
    PubMed    


  416. BADDAL B, Bostanci A, Suer K, Sanlidag T, et al
    SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00097.
    PubMed    


    February 2021
  417. PETRONE L, Petruccioli E, Alonzi T, Vanini V, et al
    In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00094.
    PubMed     Abstract available


  418. MENSAH AA, Sinnathamby M, Zaidi A, Coughlan L, et al
    SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00093.
    PubMed     Abstract available


  419. DENNY S, Abdolrasouli A, Elamin T, Gonzalo X, et al
    A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave.
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00090.
    PubMed    


  420. SCIMECA M, Mauriello S, Servadei F, Caggiano B, et al
    Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death.
    J Infect. 2021 Feb 17. pii: S0163-4453(21)00083.
    PubMed    


  421. ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
    Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
    PubMed     Abstract available


  422. BULILETE O, Lorente P, Leiva A, Carandell E, et al
    Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00080.
    PubMed     Abstract available


  423. TORRES I, Poujois S, Albert E, Alvarez G, et al
    Point-of-care evaluation of a rapid antigen test (CLINITEST() Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals.
    J Infect. 2021 Feb 12. pii: S0163-4453(21)00075.
    PubMed    


  424. YANG H, Liang X, Hou H, Xu J, et al
    The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00078.
    PubMed    


  425. LORA-TAMAYO J, Maestro G, Lalueza A, Rubio-Rivas M, et al
    Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00077.
    PubMed    


  426. NADAL M, Lassel L, Denis M, Gibelin A, et al
    ROLE OF SUPER-SPREADER PHENOMENON IN A COVID-19 CLUSTER AMONG HEALTHCARE WORKERS IN A PRIMARY CARE HOSPITAL.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00074.
    PubMed    


  427. SCUTT DG, Overall DA
    Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00056.
    PubMed    


  428. EIGNER U, Verstraeten T, Weil J
    Decrease in Norovirus infections in Germany following COVID-19 containment measures.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00076.
    PubMed    


  429. ADRIELLE DOS SANTOS L, Filho PGG, Silva AMF, Santos JVG, et al
    Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00043.
    PubMed     Abstract available


  430. KEVORKIAN JP, Lopes A, Sene D, Riveline JP, et al
    Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00058.
    PubMed    


  431. LI G, Niu J, Fan X, Chen T, et al
    The chilly climate may increase the chance of infecting COVID-19.
    J Infect. 2021 Feb 8. pii: S0163-4453(21)00057.
    PubMed    


  432. DE MONTMOLLIN E, Faille D, Andrieu V, Ajzenberg N, et al
    Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00054.
    PubMed    


  433. BELSKY JA, Tullius BP, Lamb MG, Sayegh R, et al
    COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00045.
    PubMed     Abstract available


  434. MORALES-ORTEGA A, Rivas-Prado L, Frutos-Perez B, Jaenes-Barrios B, et al
    Early clinical experience with imatinib in COVID-19: searching for a dual effect.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00051.
    PubMed    


  435. TOOVEY OTR, Harvey KN, Bird PW, Tang JWW, et al
    Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00047.
    PubMed    


  436. BORGONOVO F, Passerini M, Piscaglia M, Morena V, et al
    Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00048.
    PubMed    


  437. WILSON-DAVIES ESW, Mahanama AIK, Samaraweera B, Ahmed N, et al
    Concerns regarding the sensitivity of the OptiGene direct SARS-CoV-2 LAMP assay and its suitability for use in at-risk groups and hospital staff.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00036.
    PubMed    


  438. ALMHAWISH N, Karah N, Elferruh Y, Aksh A, et al
    Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00046.
    PubMed    


  439. TUBIANA S, Burdet C, Houhou N, Thy M, et al
    High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00049.
    PubMed    


  440. FOWLER DV, Douglas DA, Godfrey PK, Williams PA, et al
    Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff".
    J Infect. 2021;82:282-327.
    PubMed    


    January 2021
  441. DIMEGLIO C, Miedouge M, Loubes JM, Mansuy JM, et al
    Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: a modelling study from Toulouse, France.
    J Infect. 2021 Jan 31. pii: S0163-4453(21)00044.
    PubMed     Abstract available


  442. TANAKA A, Yamamoto S, Miyo K, Mizoue T, et al
    Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00032.
    PubMed    


  443. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00041.
    PubMed    


  444. T U, Am DR, Bm W, Ar H, et al
    Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients.
    J Infect. 2021 Jan 28. pii: S0163-4453(21)00040.
    PubMed    


  445. DOWNS LO, Eyre DW, O'Donnell D, Jeffery K, et al
    Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers.
    J Infect. 2021 Jan 25. pii: S0163-4453(21)00033.
    PubMed    


  446. ADACHI Y, Shiroyama T, Yamaguchi Y, Murakami T, et al
    Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study: Running head: Factors predicting respiratory failure in COVID-19.
    J Infect. 2021 Jan 24. pii: S0163-4453(21)00039.
    PubMed    


  447. ELFIKY AA, Ibrahim IM
    Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
    J Infect. 2021 Jan 22. pii: S0163-4453(21)00038.
    PubMed    


  448. XU Y, Liang H, Wen H
    Frequent reassortment and potential recombination shape the genetic diversity of influenza D viruses.
    J Infect. 2021 Jan 21. pii: S0163-4453(21)00037.
    PubMed    


  449. DE FRANCESCO MA, Poiesi C, Gargiulo F, Bonfanti C, et al
    Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features.
    J Infect. 2021 Jan 19. pii: S0163-4453(21)00031.
    PubMed    


  450. TANG JW, Toovey OTR, Harvey KN, Hui DDS, et al
    Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    J Infect. 2021 Jan 17. pii: S0163-4453(21)00030.
    PubMed    


  451. MORENO-PEREZ O, Merino E, Leon-Ramirez JM, Andres M, et al
    Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00009.
    PubMed     Abstract available


  452. BREATHNACH DAS, Riley PA, Cotter MP, Houston AC, et al
    Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00010.
    PubMed    


  453. GARCIA-ORTEGA A, Oscullo G, Calvillo P, Lopez-Reyes R, et al
    INCIDENCE, RISK FACTORS, AND THROMBOTIC LOAD OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION.
    J Infect. 2021 Jan 10. pii: S0163-4453(21)00007.
    PubMed     Abstract available


  454. GARRATT AM, Ghanima W, Einvik G, Stavem K, et al
    Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions.
    J Infect. 2021 Jan 9. pii: S0163-4453(21)00006.
    PubMed    


  455. ALEMANY A, Baro B, Ouchi D, Rodo P, et al
    Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.
    J Infect. 2021 Jan 6. pii: S0163-4453(21)00004.
    PubMed    


  456. BONGIOVANNI M, Bini F, Giuliani G, Gianturco L, et al
    Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00002.
    PubMed    


  457. NISHI A, Lee LF, Tsuji H, Takasaki Y, et al
    Letter to the Editor: Revisiting the County/city-level Event Risk Assessment during the COVID-19 Pandemic.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00003.
    PubMed    


    December 2020
  458. LIU Y, Li M, Liu D, Luo JF, et al
    Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.
    J Infect. 2020 Dec 30. pii: S0163-4453(20)30787.
    PubMed    


  459. GUO J, Yu H, Yang J, Li Y, et al
    Weighted gene co-expression network analysis revealed host transcriptional response to H1N1 influenza A virus infection.
    J Infect. 2020 Dec 29. pii: S0163-4453(20)30779.
    PubMed    


  460. TANG JW, Tambyah PA, Hui DS
    Emergence of a new SARS-CoV-2 variant in the UK.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30786.
    PubMed    


  461. YANG H, Xu J, Liang X, Shi L, et al
    Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30785.
    PubMed    


  462. HANRATH AT, Payne BAI, Duncan CJA, van der Loeff IS, et al
    Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30781.
    PubMed    


  463. CHAN HT, Chao CM, Lai CC
    Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: a meta-analysis.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30783.
    PubMed    


  464. TABOADA M, Carinena A, Moreno E, Rodriguez N, et al
    Post-COVID-19 functional status six-months after Hospitalization.: Functional status after COVID-19.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30784.
    PubMed    


  465. KONIG S, Hohenstein S, Ueberham L, Hindricks G, et al
    Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19?
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30777.
    PubMed    


  466. GANDINI O, Lubrano C
    Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.
    J Infect. 2020 Dec 20. pii: S0163-4453(20)30775.
    PubMed    


  467. TURCATO G, Zaboli A, Pfeifer N, Ciccariello L, et al
    Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report.
    J Infect. 2020 Dec 18. pii: S0163-4453(20)30773.
    PubMed    


  468. BELLANTI F, Buglio AL, Custodero G, Barbera L, et al
    Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.
    J Infect. 2020 Dec 16. pii: S0163-4453(20)30770.
    PubMed    


  469. AGULLO V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, et al
    Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
    J Infect. 2020 Dec 9. pii: S0163-4453(20)30768.
    PubMed    


  470. ZHOU H, Li C, Hu T, Liu T, et al
    Total Infectomes of 162 SARS-CoV-2 Cases Using Meta-Transcriptomic Sequencing.
    J Infect. 2020 Dec 8. pii: S0163-4453(20)30765.
    PubMed    


  471. CHEN PJ, Chao CM, Lai CC
    Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.
    J Infect. 2020 Dec 7. pii: S0163-4453(20)30766.
    PubMed    


  472. SALMON D, Slama D, De Broucker T, Karmochkine M, et al
    Clinical, virological and imaging profile in patients with Persistent or Resurgent forms of COVID-19: a cross-sectional study.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30762.
    PubMed    


  473. BARRASA H, Martin A, Maynar J, Rello J, et al
    High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time?
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30761.
    PubMed    


  474. FRICKE LM, Glockner S, Dreier M, Lange B, et al
    Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30756.
    PubMed     Abstract available


  475. PIOVANI D, Christodoulou MN, Hadjidemetriou A, Pantavou K, et al
    Effect of early application of social distancing interventions on Covid-19 mortality over the first pandemic wave: an analysis of longitudinal data from 37 countries.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30751.
    PubMed     Abstract available


  476. PANDEY M, Sisodia S, Bandi S, Roland D, et al
    Incidence of spread of clinically relevant SARS-CoV2 infection between children in a tertiary emergency department: An evaluation.
    J Infect. 2020;81:979-997.
    PubMed    


  477. FALCINELLI E, Petito E, Becattini C, De Robertis E, et al
    Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30760.
    PubMed    


    November 2020
  478. FOWLER VL, Armson B, Gonzales JL, Wise EL, et al
    A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30731.
    PubMed     Abstract available


  479. FURUSE Y
    Risk at mass-gathering events and the usefulness of complementary events during COVID-19 pandemic.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30759.
    PubMed    


  480. MAANI AA, Al-Jardani A, Karrar H, Petersen E, et al
    COVID-19 in a case previously infected with MERS-CoV: no cross immunity.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30754.
    PubMed    


  481. DUBOUCHER C
    SARS-CoV-2 and superimposed infection by trichomonads.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30757.
    PubMed    


  482. JONES CR, Hamilton FW, Thompson A, Morris TT, et al
    SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30755.
    PubMed    


  483. MOREIRA LVL, de Souza Luna LK, Barbosa GR, Perosa AH, et al
    Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30753.
    PubMed    


  484. GURGEL RQ, de Sa LC, Souza DRV, Martins AF, et al
    SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30752.
    PubMed     Abstract available


  485. LIU D, Yang J, Feng B, Lu W, et al
    Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
    J Infect. 2020 Nov 28. pii: S0163-4453(20)30726.
    PubMed     Abstract available


  486. LAI CC, Chen SY, Yen MY, Lee PI, et al
    The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.
    J Infect. 2020 Nov 26. pii: S0163-4453(20)30724.
    PubMed    


  487. LEVI M, Miglietta A, Romeo G, Bartolacci S, et al
    Letter in response to article in Journal of Infection: Impact of Routine Infant BCG Vaccination on COVID-19.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30718.
    PubMed    


  488. SUI Z, Zhang Y, Tu J, Xie J, et al
    Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30716.
    PubMed    


  489. BERASTEGUI-CABRERA J, Salto-Alejandre S, Valerio M, Perez-Palacios P, et al
    SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30719.
    PubMed    


  490. ROMERO-GOMEZ MP, Gomez-Sebastian S, Cendejas-Bueno E, Montero-Vega MD, et al
    Ct value is not enough to discriminate patients harbouring infective virus.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30720.
    PubMed    


  491. MAJRA D, Benson J, Pitts J, Stebbing J, et al
    SARS-CoV-2 (COVID-19) Superspreader Events.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30717.
    PubMed     Abstract available


  492. KOWALL B, Nonnemacher M, Brune B, Brinkmann M, et al
    A model to identify individuals with a high probability of a SARS-CoV-2 infection.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30721.
    PubMed    


  493. VOICU S, Chousterman BG, Bonnin P, Deye N, et al
    Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
    J Infect. 2020 Nov 20. pii: S0163-4453(20)30714.
    PubMed    


  494. CHAU NVV, Toan LM, Man DNH, Thao HP, et al
    Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.
    J Infect. 2020 Nov 19. pii: S0163-4453(20)30713.
    PubMed    


  495. XIONG X, Jiao X, Li H, Zeng S, et al
    Glucocorticoid benefits the ventilatory function of sever/critical COVID-19 patients.
    J Infect. 2020 Nov 18. pii: S0163-4453(20)30712.
    PubMed    


  496. BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
    Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.
    PubMed    


  497. TORRES M, Collins K, Corbit M, Ramirez M, et al
    Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.
    PubMed    


  498. POOLE S, Brendish NJ, Clark TW
    SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30707.
    PubMed     Abstract available


  499. COLSON P, Finaud M, Levy N, Lagier JC, et al
    Evidence of SARS-CoV-2 re-infection with a different genotype.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.
    PubMed    


  500. AUNG AK, Aitken T, Teh BM, Yu C, et al
    Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.
    J Infect. 2020 Nov 14. pii: S0163-4453(20)30708.
    PubMed     Abstract available


  501. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
    PubMed    


  502. RANA MS
    Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.
    PubMed    


  503. GARDINER T, Cooke G, Fidler S, Cooper N, et al
    The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.
    PubMed    


  504. CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
    SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.
    PubMed    


  505. YAN Y, Jiang X, Fu J, Huang J, et al
    Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.
    PubMed    


  506. CHARLTON M, Dashey S, Stubbs A, Lai FY, et al
    Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience.
    J Infect. 2020 Nov 9. pii: S0163-4453(20)30698.
    PubMed    


  507. JI J, Wu M, Zhong L, Liu Z, et al
    Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Nov 8. pii: S0163-4453(20)30696.
    PubMed    


  508. ROWLAND TAJ, Whitaker H, Jeffery-Smith A, Lang N, et al
    Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30695.
    PubMed    


  509. ALANIO A, Delliere S, Voicu S, Bretagne S, et al
    The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30694.
    PubMed    


  510. SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
    First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
    J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.
    PubMed    


  511. SCAGNOLARI C, Bitossi C, Frasca F, Viscido A, et al
    Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection.
    J Infect. 2020;81:726-735.
    PubMed     Abstract available


  512. SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
    Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
    J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.
    PubMed    


    October 2020
  513. WANG X, Lin L, Xuan Z, Xu J, et al
    Risk communication on behavioral responses during COVID-19 among general population in China: a rapid national study.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30689.
    PubMed     Abstract available


  514. HAMED E
    Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.
    PubMed    


  515. DIMEGLIO C, Loubes JM, Mansuy JM, Izopet J, et al
    Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
    J Infect. 2020 Oct 28. pii: S0163-4453(20)30686.
    PubMed     Abstract available


  516. ARAN D, Beachler DC, Lanes S, Overhage JM, et al
    Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30683.
    PubMed     Abstract available


  517. MERLI M, Pasulo L, Perricone G, Travi G, et al
    Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.
    PubMed    


  518. GUETL K, Moazedi-Fuerst F, Rosskopf K, Brodmann M, et al
    SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30684.
    PubMed    


  519. CHEN CH, Lai CC, Chao CM, Tang HJ, et al
    Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30679.
    PubMed    


  520. ALFEHAIDI A, Ahmed SA, Hamed E
    A case of SARS-CoV-2 re-infection.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30677.
    PubMed    


  521. MASIA M, Fernandez-Gonzalez M, Garcia JA, Padilla S, et al
    Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30676.
    PubMed    


  522. MORFELD P, Timmermann B, Gross JV, DeMatteis S, et al
    COVID-19: Spatial resolution of excess mortality in Germany and Italy.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30678.
    PubMed    


  523. WELLBELOVE Z, Walsh C, Perinpanathan T, Lillie P, et al
    Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30673.
    PubMed    


  524. DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
    Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
    J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.
    PubMed    


  525. GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
    Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
    J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.
    PubMed    


  526. YANG J, Li Y, Guo J, Luo K, et al
    Genetic characterization of an H5N6 avian influenza virus from chickens in Guangdong, China.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30656.
    PubMed    


  527. MELE M, Henares D, Pino R, Asenjo S, et al
    Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30655.
    PubMed     Abstract available


  528. WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
    Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
    J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
    PubMed     Abstract available


  529. WALSH KA, Spillane S, Comber L, Cardwell K, et al
    The duration of infectiousness of individuals infected with SARS-CoV-2.
    J Infect. 2020 Oct 10. pii: S0163-4453(20)30651.
    PubMed     Abstract available


  530. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 pandemic on Measles surveillance in Pakistan.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30650.
    PubMed    


  531. SONG W, Jia X, Zhang X, Ling Y, et al
    Co-infection in COVID-19, a cohort study.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30648.
    PubMed    


  532. JIA X, Xiao L, Liu Y
    False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30649.
    PubMed    


  533. BI J, Wang S, Wang Y, Yang D, et al
    Effect of Administering Subsequent Immune Checkpoint Inhibition in Cancer Patients with Prior COVID-19 Infection.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30647.
    PubMed    


  534. MAO MH, Guo JJ, Qin LZ, Han ZX, et al
    Serial semiquantitative detection of SARS-CoV-2 in saliva samples.
    J Infect. 2020 Oct 5. pii: S0163-4453(20)30644.
    PubMed    


  535. TANG JW, Kalliomaki P, Varila TM, Waris M, et al
    Nebulisers as a potential source of airborne virus.
    J Infect. 2020;81:647-679.
    PubMed    


  536. GREEN ST, Cladi L
    High time for an efficient and effective internationally-supported Zoonosis Surveillance System?
    J Infect. 2020;81:647-679.
    PubMed    


    September 2020
  537. DIMEGLIO C, Herin F, Miedouge M, Cambus JP, et al
    Screening for SARS-CoV-2 antibodies among healthcare workers in a University Hospital in Southern France.
    J Infect. 2020 Sep 30. pii: S0163-4453(20)30640.
    PubMed    


  538. KUNDI H, Cetin EHO, Canpolat U, Aras S, et al
    The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19.
    J Infect. 2020 Sep 28. pii: S0163-4453(20)30636.
    PubMed     Abstract available


  539. BRENDISH NJ, Poole S, Naidu VV, Mansbridge CT, et al
    Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30638.
    PubMed     Abstract available


  540. SIXT T, Moretto F, Devilliers H, Abdallahoui M, et al
    The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30639.
    PubMed    


  541. MOISEEV S, Brovko M, Tao E, Bulanov N, et al
    Sex differences in mortality in the intensive care unit patients with severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30635.
    PubMed    


  542. HUANG W, Wu Q, Chen Z, Xiong Z, et al
    The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30632.
    PubMed    


  543. MIYAZAWA DD
    Letter in response to article in journal of infection: "Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study".
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30637.
    PubMed    


  544. SEATON RA, Gibbons CL, Cooper L, Malcolm W, et al
    Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30616.
    PubMed     Abstract available


  545. SALTO-ALEJANDRE S, Roca-Oporto C, Martin-Gutierrez G, Aviles MD, et al
    A quick prediction tool for unfavourable outcome in COVID-19 inpatients:development and internal validation.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30619.
    PubMed    


  546. WANG S, Fu L, Huang K, Han J, et al
    Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019.
    J Infect. 2020 Sep 23. pii: S0163-4453(20)30630.
    PubMed    


  547. STANG A, Standl F, Kowall B, Brune B, et al
    Excess mortality due to COVID-19 in Germany.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30596.
    PubMed     Abstract available


  548. PAGANI G, Conti F, Giacomelli A, Bernacchia D, et al
    Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30629.
    PubMed    


  549. PAN D, Sze S, Rogers B, Bron J, et al
    Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30623.
    PubMed    


  550. JUAN HC, Chao CM, Lai CC, Tang HJ, et al
    Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30624.
    PubMed    


  551. KOW CS, Hasan SS
    The use of antimotility drugs in COVID-19 associated diarrhea.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30592.
    PubMed    


  552. ORTH-HOLLER D, Eigentler A, Stiasny K, Weseslindtner L, et al
    Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30593.
    PubMed    


  553. SORIANO MC, Vaquero C, Ortiz-Fernandez A, Caballero A, et al
    Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
    J Infect. 2020 Sep 18. pii: S0163-4453(20)30594.
    PubMed    


  554. LADHANI SN, Chow JY, Atkin S, Brown KE, et al
    REGULAR MASS SCREENING FOR SARS-CoV-2 INFECTION IN CARE HOMES ALREADY AFFECTED BY COVID-19 OUTBREAKS: implications of false positive test results.
    J Infect. 2020 Sep 16. pii: S0163-4453(20)30621.
    PubMed    


  555. GANDINI O, Criniti A, Ballesio L, Giglio S, et al
    Serum ferritin as an independent risk factor for acute respiratory distress syndrome in COVID-19 patients in Rome Italy.
    J Infect. 2020 Sep 15. pii: S0163-4453(20)30617.
    PubMed    


  556. TANG HJ, Lai CC
    The association between corticosteroid uses and mortality among severe COVID-19 patients.
    J Infect. 2020 Sep 12. pii: S0163-4453(20)30599.
    PubMed    


  557. ISHII M, Terai H, Kabata H, Masaki K, et al
    Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30590.
    PubMed    


  558. ELFIKY AA, Ibrahim IM, Ismail AM, Elshemey WM, et al
    A possible role for GRP78 in cross vaccination against COVID-19.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30598.
    PubMed    


  559. RANA DMS, Usman MM, Alam DMM, Khalid DA, et al
    First trimester miscarriage in a pregnant woman infected with COVID-19 in Pakistan.
    J Infect. 2020 Sep 4. pii: S0163-4453(20)30587.
    PubMed    


  560. BONGIOVANNI M, Zago T
    Acute hepatitis caused by asymptomatic COVID-19 infection.
    J Infect. 2020 Sep 3. pii: S0163-4453(20)30586.
    PubMed    


  561. CHEN HJ, Lin HJ, Wu MC, Tang HJ, et al
    The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases.
    J Infect. 2020 Sep 2. pii: S0163-4453(20)30585.
    PubMed    


  562. BARNETT WR, Radhakrishnan M, Macko J, Hinch BT, et al
    Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study.
    J Infect. 2020 Sep 2. pii: S0163-4453(20)30583.
    PubMed    


  563. KEVORKIAN JP, Riveline JP, Vandiedonck C, Girard D, et al
    Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
    J Infect. 2020 Sep 1. pii: S0163-4453(20)30579.
    PubMed    


    August 2020
  564. AXELL-HOUSE DB, Lavingia R, Rafferty M, Clark E, et al
    The Estimation of Diagnostic Accuracy of Tests for COVID-19: A Scoping Review.
    J Infect. 2020 Aug 31. pii: S0163-4453(20)30577.
    PubMed     Abstract available


  565. YANYAN, Jiang X, Wang X, Liu B, et al
    CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity.
    J Infect. 2020 Aug 29. pii: S0163-4453(20)30576.
    PubMed    


  566. GRALL I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, et al
    Viral spreading in asymptomatic cases with SARS-CoV-2 infections: a Pilot study.
    J Infect. 2020 Aug 29. pii: S0163-4453(20)30578.
    PubMed    


  567. KANAMORI H
    Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare.
    J Infect. 2020 Aug 27. pii: S0163-4453(20)30575.
    PubMed    


  568. NSN G, C J, R M, P R, et al
    High rates of SARS-CoV-2 seropositivity in nursing home residents.
    J Infect. 2020 Aug 26. pii: S0163-4453(20)30574.
    PubMed    


  569. DE LUSIGNAN S, Joy M, Oke J, McGagh D, et al
    Disparities in the excess risk of mortality in the first wave of COVID-19: cross sectional study of the English sentinel network.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30564.
    PubMed     Abstract available


  570. LEI H, Xu X, Xiao S, Wu X, et al
    Household transmission of COVID-19-a systematic review and meta-analysis.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30571.
    PubMed    


  571. LANDI F, Gremese E, Rota E, Carfi' A, et al
    Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30565.
    PubMed    


  572. GARRIGUES E, Janvier P, Kherabi Y, Bot AL, et al
    Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30562.
    PubMed    


  573. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30568.
    PubMed    


  574. KORTE W, Buljan M, Rosslein M, Wick P, et al
    SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30567.
    PubMed    


  575. ARSHAD Y, Mahmood N, Zaidi SSZ, Sharif S, et al
    Detection of SARS-CoV-2 in ophthalmic secretions in Pakistan: A preliminary report.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30569.
    PubMed    


  576. YAN Y, Liu B, Ding H, Wang X, et al
    Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30566.
    PubMed    


  577. KROEMER M, Spehner L, Vettoretti L, Bouard A, et al
    COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30563.
    PubMed     Abstract available


  578. HE L, Zeng Y, Zeng C, Zhou Y, et al
    Positive Rate of Serology and RT-PCR for COVID-19 among Healthcare Workers during Different Periods in Wuhan, China.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30561.
    PubMed    


  579. GROSSI E, Terruzzi V
    Exceptionally high COVID-19 viral load and very long duration of shedding in a young pauci-symptomatic child with autism resident in an Italian nursing home.
    J Infect. 2020 Aug 22. pii: S0163-4453(20)30560.
    PubMed    


  580. LI Z, Xu H, Chen J, Pang Z, et al
    Internet-based remote consultation facilitates the medical care of patients with chronic skin diseases during COVID-19 pandemic.
    J Infect. 2020 Aug 21. pii: S0163-4453(20)30559.
    PubMed    



  581. Clinical characteristics and outcome of COVID-19 pneumonia in elderly subjects.
    J Infect. 2020 Aug 19. pii: S0163-4453(20)30557.
    PubMed    


  582. NAKAJIMA K, Abe T, Saji R, Ogawa F, et al
    Serum cholinesterase associated with COVID-19 pneumonia severity and mortality.
    J Infect. 2020 Aug 19. pii: S0163-4453(20)30555.
    PubMed    


  583. BONGIOVANNI M, Vignati M, Giuliani G, Manes G, et al
    The dilemma of COVID-19 recurrence after clinical recovery.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30553.
    PubMed    


  584. LIM RH, Chow A, Ho HJ
    Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30554.
    PubMed    


  585. KELLENI MT
    SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30552.
    PubMed    


  586. YUAN Y, Liu D, Zeng S, Wang S, et al
    In-hospital Use of ACEI/ARB is associated with lower Risk of Mortality and Critic Illness in COVID-19 Patients with Hypertension: ACEI/ARB protect COVID-19 patients.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30548.
    PubMed    


  587. SADDIQUE A, Rana MS, Alam MM, Ikram A, et al
    "Emergence of co-infection of COVID-19 and dengue: A serious public health threat ".
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30545.
    PubMed    


  588. TOMASSINI S, Kotecha D, Bird PW, Folwell A, et al
    Setting the criteria for SARS-CoV-2 reinfection - six possible cases.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30546.
    PubMed    



  589. Previous cardiovascular surgery significantly increases the risk of developing critical illness in patients with COVID-19.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30544.
    PubMed    


  590. KINOSHITA M, Tanaka M
    Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30547.
    PubMed     Abstract available


  591. LUIS GARCIA DE GUADIANAROMUALD, Mulero MDR, Olivo MH, Rojas CR, et al
    Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: a case series.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30543.
    PubMed    


  592. DAI CY, Dai TH, Ho HY, Ho CK, et al
    The strategies for the Coronavirus Disease 2019 (COVID-19) in Taiwan: A different tale.
    J Infect. 2020 Aug 10. pii: S0163-4453(20)30542.
    PubMed    


  593. KIM YJ, Jeong YJ, Kim SH, Oh AR, et al
    Preparing for long-term non-face-to-face outpatient care services during the COVID-19 pandemic.
    J Infect. 2020 Aug 7. pii: S0163-4453(20)30540.
    PubMed    


  594. AL-HATMI AMS, Mohsin J, Al-Huraizi A, Khamis F, et al
    COVID-19 associated invasive candidiasis.
    J Infect. 2020 Aug 6. pii: S0163-4453(20)30539.
    PubMed    


  595. HAN J, Gong H, Fu L, Chen P, et al
    Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30536.
    PubMed    


  596. BIRGAND G, Blanckaert K, Deschanvres C, Vaudron A, et al
    Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30535.
    PubMed    


  597. BOGLIONE L, Rostagno R, Poletti F, Moglia R, et al
    The proper use of corticosteroids for 2019-nCov pneumonia: towards promising results?
    J Infect. 2020 Aug 4. pii: S0163-4453(20)30534.
    PubMed    


  598. WANG Y, Chow A
    Dancing with COVID-19 after the Hammer is Lifted: Enhancing Healthcare Worker Surveillance.
    J Infect. 2020 Aug 1. pii: S0163-4453(20)30533.
    PubMed    


  599. GLATMAN-FREEDMAN A, Kaufman Z, Applbaum Y, Dichtiar R, et al
    Respiratory Syncytial Virus hospitalization burden: a nation-wide population-based analysis, 2000-2017.
    J Infect. 2020;81:297-303.
    PubMed     Abstract available


  600. ELKINGTON P, Morgan H
    Personal respirators for population level control of the COVID19 pandemic.
    J Infect. 2020;81:318-356.
    PubMed    


    July 2020
  601. DE ABREU MC
    SARS-CoV-2 IgM and IgG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30513.
    PubMed    


  602. CHETRIT A, Lechien JR, Ammar A, Chekkoury-Idrissi Y, et al
    Magnetic Resonance Imaging of COVID-19 Anosmic Patients Reveals Abnormalities of the Olfactory Bulb: Preliminary Prospective Study.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30509.
    PubMed    


  603. HAMILTON F, Muir P, Attwood M, Vipond ANB, et al
    Kinetics and performance of the Abbott Architect SARS-CoV-2 IgG antibody assay.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30510.
    PubMed    


  604. PALLETT SJC, Jones R, Pallett MA, Rayment M, et al
    Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30511.
    PubMed    


  605. BLAIRON L, Mokrane S, Wilmet A, Dessilly G, et al
    Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30514.
    PubMed    


  606. LADHANI SN, Chow JY, Janarthanan R, Fok J, et al
    INCREASED RISK OF SARS-CoV-2 INFECTION IN STAFF WORKING ACROSS DIFFERENT CARE HOMES ENCHANCED CoVID-19 OUTBREAK INVESTIGATIONS IN LONDON CARE HOMES.
    J Infect. 2020 Jul 28. pii: S0163-4453(20)30508.
    PubMed     Abstract available


  607. LU QB, Jiang WL, Zhang X, Li HJ, et al
    Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study.
    J Infect. 2020 Jul 27. pii: S0163-4453(20)30507.
    PubMed    


  608. WU J, Xie X, Yang L, Xu X, et al
    Mobile health technology combats Covid-19 in China.
    J Infect. 2020 Jul 27. pii: S0163-4453(20)30505.
    PubMed     Abstract available


  609. TU D, Shu J, Wu X, Li H, et al
    Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2.
    J Infect. 2020 Jul 25. pii: S0163-4453(20)30504.
    PubMed    


  610. BARNACLE JR, Cairney G, Rainsley J, Mercuri L, et al
    Changes in the hospital admission profile of COVID-19 positive patients at a central London trust.
    J Infect. 2020 Jul 23. pii: S0163-4453(20)30501.
    PubMed    


  611. GIL E, Weller S, Rokadiya S, Mirfenderesky M, et al
    Letter in Response to 'Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown' Local Experience, National Questions. How Local is Local Enough?
    J Infect. 2020 Jul 23. pii: S0163-4453(20)30492.
    PubMed    


  612. BI J, Lin Y, Zhong R, Jiang G, et al
    Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30493.
    PubMed    


  613. VILLAR LM, da Costa VD, Marques BL, da Silva LL, et al
    USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30491.
    PubMed    


  614. SHUAI H, Chu H, Hou Y, Yang D, et al
    Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-beta and IFN inducer.
    J Infect. 2020 Jul 21. pii: S0163-4453(20)30490.
    PubMed     Abstract available


  615. ROSSOTTI R, Travi G, Ughi N, Corradin M, et al
    SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30467.
    PubMed     Abstract available


  616. SALMON D, Bartier S, Hautefort C, Nguyen Y, et al
    Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter CORANOSMIA cohort study.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30463.
    PubMed     Abstract available


  617. LU L, Zhong W, Bian Z, Li Z, et al
    A Comparison of Mortality-related Risk Factors of COVID-19, SARS, and MERS: A Systematic Review and Meta-analysis.
    J Infect. 2020 Jul 4. pii: S0163-4453(20)30460.
    PubMed     Abstract available


  618. HUANG W, Lin D, Wang C, Bao C, et al
    The determination of release from isolation of COVID-19 patients requires ultra-high sensitivity nucleic acid test technology.
    J Infect. 2020 Jul 2. pii: S0163-4453(20)30456.
    PubMed    


  619. ZHOU J, Tan Y, Li D, He X, et al
    Observation and analysis of 26 cases of asymptomatic SARS-COV2 infection.
    J Infect. 2020;81:e69-e70.
    PubMed    


    June 2020
  620. BATISSE D, Benech N, Botelho-Nevers E, Bouiller K, et al
    Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30454.
    PubMed     Abstract available


  621. GIANNIS D, Ziogas IA
    Letter in response to article in journal of infection: "Cardiovascular complications in COVID-19: A systematic review and meta-analysis".
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30455.
    PubMed    


  622. PRAZUCK T, Giache S, Gubavu C, Colin M, et al
    Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30448.
    PubMed    


  623. LIN Z, Long F, Yang Y, Chen X, et al
    Serum ferritin as an independent risk factor for severity in COVID-19 patients.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30434.
    PubMed    


  624. BOUZA E, Perez-Granda MJ, Escribano P, Fernandez-Del Rey R, et al
    OUTBREAK OF COVID-19 IN A NURSING HOME IN MADRID.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30437.
    PubMed    


  625. CANTINI F, Niccoli L, Nannini C, Matarrese D, et al
    Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30433.
    PubMed    


  626. DAUNT A, Perez-Guzman PN, Liew F, Hauck K, et al
    Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30430.
    PubMed    


  627. CLARK TW, Brendish NJ, Poole S, Naidu VV, et al
    Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30432.
    PubMed     Abstract available


  628. HATTORI T, Amishima M, Morinaga D, Kamada K, et al
    Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30428.
    PubMed    


  629. GAO Y, Shi C, Chen Y, Shi P, et al
    A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China.
    J Infect. 2020;80:666-670.
    PubMed     Abstract available


    May 2020
  630. SZE S, Pan D, Williams CML, Wong N, et al
    Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19.
    J Infect. 2020 May 29. pii: S0163-4453(20)30341.
    PubMed    


  631. WONG MC, Teoh JY, Huang J, Wong SH, et al
    The potential impact of vulnerability and coping capacity on the pandemic control of COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30337.
    PubMed    


  632. MEYLAN S, Akrour R, Regina J, Bart PA, et al
    An Early Warning Score to predict ICU admission in COVID-19 positive patients.
    J Infect. 2020 May 28. pii: S0163-4453(20)30324.
    PubMed    


  633. SAGNELLI C, Gentile V, Tirri R, Macera M, et al
    Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
    J Infect. 2020 May 28. pii: S0163-4453(20)30322.
    PubMed    


  634. HU J, Zhang X, Zhang X, Zhao H, et al
    COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.
    J Infect. 2020 May 28. pii: S0163-4453(20)30334.
    PubMed    


  635. COLTON H, Ankcorn M, Yavuz M, Tovey L, et al
    Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.
    J Infect. 2020 May 28. pii: S0163-4453(20)30339.
    PubMed    


  636. KUNUTSOR SK, Laukkanen JA
    Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30325.
    PubMed    


  637. VARIKASUVU SR, Dutt N
    Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.
    J Infect. 2020 May 27. pii: S0163-4453(20)30316.
    PubMed    


  638. BORGHETTI A, Ciccullo A, Paratore M, Rovedi F, et al
    Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
    J Infect. 2020 May 27. pii: S0163-4453(20)30321.
    PubMed    


  639. KLEMENT-FRUTOS E, Burrel S, Peytavin G, Marot S, et al
    Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
    J Infect. 2020 May 27. pii: S0163-4453(20)30318.
    PubMed     Abstract available



  640. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.
    J Infect. 2020 May 27. pii: S0163-4453(20)30317.
    PubMed    


  641. NOH JY, Yoon JG, Seong H, Choi WS, et al
    Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.
    J Infect. 2020 May 21. pii: S0163-4453(20)30310.
    PubMed    


  642. TANG JW, Young S, May S, Bird P, et al
    Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic.
    J Infect. 2020 May 19. pii: S0163-4453(20)30308.
    PubMed    


  643. CAI C, Ahmed OA, Shen H, Zeng S, et al
    Which cancer type has the highest risk of COVID-19 infection?
    J Infect. 2020 May 19. pii: S0163-4453(20)30307.
    PubMed    


  644. SHI L, Wang Y, Wang Y, Duan G, et al
    Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.
    J Infect. 2020 May 14. pii: S0163-4453(20)30288.
    PubMed    


  645. JAYARAJ R
    Clinical and conceptual comments on "Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis".
    J Infect. 2020 May 11. pii: S0163-4453(20)30287.
    PubMed    


  646. WANG D, Zhou M, Nie X, Qiu W, et al
    Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China.
    J Infect. 2020;80:e25-e27.
    PubMed    


    January 2020
  647. TOIVONEN L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, et al
    Respiratory syncytial virus infections in children 0-24 months of age in the community.
    J Infect. 2020;80:69-75.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: